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ABSTRACT 
 
 
The purpose of this study was to examine isometric strength, pain threshold and 
perceived health responses to partial-body cryotherapy (PBC, 150s at a 
temperature range between -130 and -160°C).  
Three different populations of subjects were enrolled for this study: 200 healthy 
people were exposed to a single PBC session in order to assess the maximum 
handgrip isometric strength responses by means of an hydraulic dynamometer, 
30 healthy female carried out a cycle of ten consecutive PBC sessions for 
evaluate the objective pain threshold in the low back region via the pain-
pressure test and finally 28 female fibromyalgic patients were exposed to 
repeated exposure to PBC (ten sessions in a row) with the purpose to examine 
perceived health and quality of life responses utilizing two self-reported 
questionnaires. 
A single session of PBC lead to improve, immediately after the very-low 
temperatures exposure, muscle isometric strength in healthy people both in 
females and in males. Repeated exposures to PBC in healthy women was 
shown to be efficient in decreasing very rapidly the skin temperature in the low-
back region, and thus to induce a significant increase in pain-pressure threshold 
values. The same protocol of repeated exposures to PBC induced significant 
improvements for all indexes and sub-indexes of the perceived health and 
quality of life questionnaires assessed in fibromyalgic patients.  
 
 
KEYWORDS: partial-body cryotherapy, cryostimulation, cold exposure, 
isometric strength, pain threshold, fibromyalgia, quality of life. 
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1. INTRODUCTION 
 
Since I was studying for my master’s degree I focused my attention on recovery 
strategies, more than on training methods, so that I decided to do an 
experimental thesis about cold water immersion after training in young soccer 
players. With great satisfaction it was published on The Journal of Sports 
Medicine and Physical Fitness in 2011 entitled “Effects of cold-water immersion 
and contrast-water therapy after training in young soccer players” (De Nardi et 
al, 2011). This allowed me to get interested on different applications of the cold 
therapy and I have experienced many devices based on cold therapy such as 
cold packs, cold immersion and cold garments. In that period I was particularly 
impressed by a relatively new type of cold therapy, the whole-body cryotherapy, 
which was getting a growing interest in the scientific community, clinicians and 
sports scientists worldwide. Whole-body cryotherapy has been developed in 
Japan since 1978 and arrived in Italy only in 2010, when in Orzinuovi a group of 
businessmen opened the BonGi polyclinic, the first one in our country to have 
used a cryochamber and a cryosauna. I was lucky to have got a job there, so I 
could deepen my knowledge on whole-body cryotherapy and collect data that I 
could use for my studies at the time. After working a year in that structure, I 
decided to open my own cryotherapy laboratory that I called Krioplanet: it was 
an opportunity to collect data daily and this led me to publish three articles over 
a period of two years. This is the path that induced me to request the admission 
to the PhD course, with the purpose of studying the topic of the whole-body 
cryotherapy in the field of sport recovery and in its different applications. In the 
last three years I worked on different research protocols and on different drafts 
of which I will talk about in the next chapters. My research activity also allowed 
me to participate as a speaker in different conferences and it also made me to 
join the working group on whole-body cryotherapy of the International Institute 
of Refrigeration. 
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2. REVIEW OF LITERATURE 
 
2.1 PHYSIOLOGICAL PRINCIPLES RELATED TO CRYOTHERAPY 
 
It is known there are six basic parameters that define human thermal 
environments: air temperature, radiant temperature, humidity and air movement, 
combined with the metabolic heat generated by human activity and clothing 
worn by individual. Thus, we are talking about a multifactorial approach: the 
interaction of the six factors to which humans respond (Fanger, 1970). Humans 
are homeotherms and are strictly subjected to maintain a constant core 
temperature (a narrow range around 37°C to avoid serious consequences in 
case of a marked difference from this value). The human body is usually 
surrounded by clothes and by air, but sometimes also with liquid surfaces as 
water, other fluids and space. The temperature of the human body will hence be 
greatly influenced by the temperature of air, fluids and solids surrounding it: core 
temperature remains almost constant despite varying ambient thermal 
conditions while skin temperature can vary considerably, in particular in cold 
environments. As already written the internal temperature should be maintained 
at around 37°C, so heat transfer into the body and heat generation within the 
body must be balanced by heat outputs from the body: we can summarize that 
for a constant temperature there will be a dynamic balance and not a steady 
state. It is important for the body to achieve a dynamic equilibrium. Indeed, 
external conditions continually change, so it has to respond regulating internal 
body temperature, not only maintaining internal temperature at around 37°C, but 
also maintaining every cell of the body at a temperature level which prevents 
damage. The temperature of the human body is an important indicator of its 
condition (comfort, heat or cold stress, health, sickness, performance, etc.). The 
primary control center for thermoregulation is the hypothalamus. In literature 
there are few proposed models of human thermoregulation and they all agree 
that when the body is exposed to hot it loses heat by vasodilatation and 
eventually sweating to allow cooling by evaporation; conversely if the body 
becomes cold the heat is maintained by vasoconstriction and, if needed, it is 
generated by shivering (Parsons, 2003). Shivering can increase metabolic heat 
production up to six times (Kenatinge et al, 1986) and when exposing to very 
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low temperature, as for example in whole- and partial-body cryotherapy, it can 
arrests the fall in core temperature. There are two types of thermal sensitive 
receptors: warm or cold types, depending to the response to stimuli. They are 
located in the skin (over and within epidermis), in the hypothalamus and in other 
sites as blood vessels, midbrain, etc. Afferent signals from the peripheral 
receptors are transferred by nervous pathways to the hypothalamus: warm 
signals are mediated by anterior hypothalamus, while cold signals by posterior 
hypothalamus. The core temperature is maintained at a constant temperature 
while as a part the thermoregulation the mean skin temperature varies over the 
whole of the body. Humans could be subjected to both hot stress and cold 
stress. When the body is exposed to cold environments first of all 
vasoconstriction reduces blood flow to the skin and therefore heat loss, then 
non-shivering thermogenesis such as stiffness will increase metabolic rate, 
lastly shivery begins. Individuals respond to cold stress differently: body size, 
gender, age, fat percentage and fitness level are important factors which can 
induce to different thermal responses. For example subjects with a high fat 
percentage tend to have a core temperature higher than people with less fat % 
after cold exposure, especially regarding male subjects (Cuttel et al., 2017) as 
well as individuals with higher adiposity cooling more at the skin than thinner 
ones (Hammond et al., 2014). That is the reason why females, those usually 
have a greater body fat percentage than males, experienced a greater degree 
of skin cooling. Age difference could be a discriminant in the response to cold 
agents: elderly people are in fact more susceptible to the cold, the same goes 
for people with a low fitness level that is related with a lower metabolic rate than 
individuals which practice exercise with constancy (Castellani et al. 2006). 
Another individual factors to take in account is the body surface area-to-mass 
ratio: subjects with a greater values experience a more rapid fall in core 
temperature (Sloan & Keating, 1973).  
Cryotherapy, i.e. the exposure for a certain time to cold environments or agents, 
can lead to acute and long term physiological responses such as circulatory, 
respiratory and neuromuscular ones. Physiological reactions after acute 
exposure to the cold are mediated by the sympathetic and parasympathetic 
nervous systems. During a cold exposure, cardiac workload, systolic and 
diastolic blood pressure significantly increase in healthy subjects (Li et al., 2009; 
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Korhonen, 2006). This might increase the risk of cardiovascular events in 
subjects with cardiac diseases (Hong et al., 2016; Ikaheimo T.M., 2018). Also 
respiratory system is subjected to significant changes during acute or chronic 
cold exposures: cold elicits an increase in pulmonary vascular resistance and 
chronic exposure induced morphological changes such as increased numbers 
of goblet cells and mucous glands, hypertrophy of airway muscular fascicles and 
increased muscle layers of terminal arteries and arterioles (Giesbrecht G.G., 
1995). At the same time neuromuscular performance changes in the cold: 
dynamic exercise, which involves eccentric and concentric contraction, 
decreases because the co-ordination of muscles changes. In fact, while 
shivering occurs, antagonist muscles co-contract together, “fighting” against 
each other (Bawa et al. 1987). Isometric exercise is not subjected to this 
phenomenon (Burke D.G. et al., 2000). Another factor influenced by cold is the 
postural control: cold exposure impair postural sway in healthy males increasing 
the velocity of the center of pressure position in the medial-lateral position in the 
bipedal position while subjects stood on a force plate (Fukuchi C.A. et al, 2014). 
 
 
2.2  WHOLE-BODY CRYOTHERAPY AND PARTIAL-BODY 
CRYOTHERAPY 
 
Cryotherapy has ancient origins, in medicine it was used by several cultures: 
Egyptians first discovered the invigorating benefits of cold-water immersion, 
Romans were known to plunge in rivers after battles and Persians used cold 
remedies to treat a wide range of disease. Hippocrates, the father of western 
medicine prescribed ice-cold water as optimal treatment for relieving swelling, 
pain and inflammation. Nowadays the use of cold application has become very 
popular in medicine, health care and within sport therapists. Ice packs, winter 
swimming, cold-water immersion and cold garments are studied by scientific 
community and prescribed by the 80% of physicians as a symptomatic treatment 
following soft tissues injuries, distortions, contusions and overuse symptoms.  
A peculiar form of exposure to extremely cold dry air in an environmentally 
controlled room for a short period of time was proposed in 1978 for the treatment 
of rheumatic diseases: this treatment was named whole-body cryotherapy 
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(WBC). The Japanese physician Prof. Toshiro Yamauchi built the first 
cryochamber, after observed his rheumatologic patients coming back from 
winter holidays spent in mountain feeling better. Originally it was developed to 
treat rheumatoid arthritis (Yamauchi, 1986) and other chronic pathologies as for 
example multiple sclerosis, fibromyalgia and ankylosing spondylitis. More 
recently it has gained greater acceptance in sports medicine as a method to 
improve recovery from intense exercise and injury (Banfi et al, 2010; Lombardi 
et al., 2017). This cold treatment is usually called “cryostimulation” if it is 
addressed to healthy people, that is without pathologies and “cryotherapy” if it 
is addressed to patients. Curiously, in a recent paper, Roszkowska and co-
workers (2018) stated that it will be recommended also in animals such as 
horses, to shorten the recovery period after injury and to improve the muscular 
tiredness. 
In the last decades besides local cryotherapy two extreme forms of cryotherapy 
were developed (Bouzigon et al, 2016): whole-body cryotherapy (WBC), as 
already mentioned and partial-body cryotherapy (PBC). Each form of cold 
therapy expose subject to very cold dry air for a short period of time and require 
a specialized cold controlled environment: a cryochamber (WBC) or a cryocabin 
(PBC). They differs each other for some aspects: the temperature range (-110°C 
for WBC and -160°C for PBC), the head exposed to the cold in WBC while is 
not exposed in PBC, the way to generate cold (compressor for WBC and 
nitrogen gas for PBC), mobility possibilities due to different device and nitrogen 
tank sizes (impossible to move for WBC unless in the case of the portable unit 
which can be pulled by a truck, possibility to move for PBC both for quite small 
size of the device and for the ease of movement of the nitrogen tank), in WBC 
enters a small group (generally from 2 to 4 people) and in PBC enters alone 
(Hausswirth et al, 2013). An interesting dissertation of actual technologies can 
be found in the paper written by Bouzigon and colleagues in 2016, where they 
summarize fourteen producers worldwide. To our best knowledge nowadays 
there are many others producers on the market (VacuActiv, CryoScience, CTN, 
Lifecube, MCryo, CryoPod, CryoInnovations, Aurora Concept and CryoNext). 
One of the main differences of these devices is the way to generate cold: 
cryochambers could be hybrid (nitrogen mixed to air) or electrical (electric 
energy) while cryocabins could be cooled only by nitrogen. One of the key points 
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is that the actual temperature in the two types of devices is not precisely 
assessed: it is not known for example the site of assessment of chambers and 
cabins, so there is not standardization in assessing the temperature inside the 
device during the session. One study measured the actual temperature in a 
specific model of cryocabin (Criomed Space Cabin) with the empty cabin and 
with a manikin, and authors showed the temperature in the cabin was not 
homogeneous. The temperature in the cabin was different between the top of 
the cabin and the lowest part of it and between the front side (near the door) and 
the back side (near the nitrogen nozzle), showing that the actual temperature in 
the cryocabin was different compared to that reported by the manufacturer 
(Savic et al., 2013). This is a very huge problem for the validity and the 
reproducibility of scientific protocols, and comparing data from different research 
is quite difficult. In addition there is a lack of the literature on the comparative 
efficiency of the two methods, that is why, for example, the decision to switch 
from a former of device to the other is arbitrary and without any scientific criteria.  
There are only three studies, to our best knowledge which compared WBC and 
PBC: two of which evaluated the effects of a single session (Hausswirth et al., 
2013; Polidori et al., 2018) and one the other one assessed the effects of a cycle 
of five consecutive sessions (Louis et al., 2015). In their research Hausswirth 
and colleagues compared the effects of a single session of whole- and partial-
body cryotherapy on indices of parasympathetic activity, blood catecholamines 
and thermal comfort: they recorded changes in thermal variables such as skin 
temperature, for which they found an almost certainly decrease both after  WBC 
(-110°C) and PBC (-160°C), and tympanic temperature (almost certainly 
decreased only after the WBC session). They evaluated cardiovascular 
parameters such as blood pressure (very liked increased after the WBC 
session), heart rate for which they found an almost certainly decreased after 
PBC and WBC, with a likely greater proportion for WBC compared to PBC (-
15.2% vs -10.9%) and the resting vagal-related heart rate variability indices 
which very liked increased after PBC and WBC without significant differences 
between groups. As regards blood catecholamines plasma norepinephrine likely 
increased after PBC and very likely increase after WBC (+54.7% and +76.2%). 
Lastly thermal cold sensation was almost certainly altered after WBC and PBC, 
with thermal discomfort likely more pronounced after WBC than PBC. Summing 
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up their outcomes showed that a WBC session induced a larger stimulation of 
the autonomic nervous system compared to a PBC session. In their second 
published research on this topic the French research group (Louis et al., 2015) 
studied the influence of exposing the head to cold during cryotherapy sessions 
on the thermal response and the autonomic nervous system. This study was 
conducted over five consecutive days with two groups of ten participants 
involved in the two different systems and another group of ten subjects 
constituting a control group not receiving any cryostimulation. WBC (-60°C) and 
PBC (-160°C) sessions, induced the same decrease in skin temperature for all 
body regions (-8.6°C for WBC and -8.3°C for PBC) which persisted up to 20-min 
after the sessions. They also found that tympanic temperature significantly 
decreased after WBC whilst decreased, but without any statistical significance, 
after PBC. As regards heart rate they found an almost certainly decrease both 
after PBC (-8.6%) and WBC (-12.3%) sessions. Resting vagal-related heart rate 
variability indices likely increased after PBC and almost certainly increased after 
WBC. Lastly plasma norepinephrine concentration was likely increased in 
similar proportion after each cryotherapy treatment, but only after the first 
session. Summing up their results they assumed that the head exposure to cold 
during cryotherapy session in a cryochamber may not be the main factor 
responsible for the effects of cryostimulation on the autonomic nervous system. 
Another French group (Polidori et al., 2018) recently focused their research on 
the difference between PBC and WBC based on the analysis of skin 
temperature distribution. They noticed that skin temperature difference between 
PBC (-140°C) and WBC (-140°C) varied according to the vertical location of the 
body regions, increasingly from 15% on the legs (p=.171) up to the 53% for the 
chest (p<0.001).  
All authors agree that more experimental approaches are needed to improve the 
cryotherapy protocols used, especially when the choice can be made between 
WBC and PBC: just need to think that also in the three above mentioned 
publication they have set three different temperature levels (-110°C; -60°C; -
140°C) for the whole-body cryotherapy sessions. The lack of standardization in 
protocols, understood as different temperatures, duration and numbers of the 
exposures makes it difficult to fix the difference between PBC and WBC, also 
taking account the individual different characteristics of each fellow.  
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These two methodologies have in common that people enter in the cold 
environments minimally dressed, with socks, gloves,  wooden clogs and, for as 
concerned the WBC, with headband and mask for the nose. For the entire 
duration of the treatment subjects have to walk on the spot and breath regularly. 
Visual and vocal contact between the subject and the operator or the physician 
in the PBC is made possible because the head of the subject is outside the 
cryocabin while in the WBC is allowed by a glass window put into the wall of the 
cryochamber and a microphones system. Typically the timescale of exposure is 
reported as between 2-4 minutes: in their research Selfe et al. (2014) 
established a duration time of 2 minutes of WBC exposure at -135°C as a safe 
protocol for future applications for male elite rugby players, while Fonda and 
colleagues (2014) concluded that the optimal duration for PBC is 150 seconds 
with a temperature range between -130°C and -170°C. Recently the topic of the 
standardization of the protocol has gained more interest because the same cold 
stimulus at the same temperature for the same time frame could be perceived 
in different ways by different subjects: in fact the key point is to assess 
individualized exposure protocols for the different anthropometric and gender 
characteristics in addition to their health status and fitness level. To the best of 
our knowledge only four studies compared the different response after a whole-
body cryotherapy session between subjects with different BMI or gender. All of 
them were performed utilizing a cryochamber, so we can assume that there are 
no data in literature about this topic with PBC technology. The first to address 
this topic were Cholewka and colleagues in 2011: in their research they utilized 
a thermovision camera and a contact thermometer with thermocouples. The 
conclusions of this study were that the largest decrease in skin temperature was 
observed on the lower extremities with differences in the thermal response 
influenced by the BMI. In 2014 Hammond et colleagues explored whether 
anthropometric measures influenced skin temperature after a WBC session and 
observed that the lowering in skin temperature was more significant in females 
than in males and found also a significant relationship between body fat 
percentage and decrease of skin temperature. In 2017 Cuttel and colleagues 
investigated the effects of whole-body cryotherapy in temperature, heart rate, 
blood pressure, thermal comfort and sensation between males and females. 
They found sex differences and in mean arterial pressure, mean skin and mean 
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body temperature following exposure to whole-body cryotherapy. Recently 
Polidori and colleagues investigated how body thermal resistance between 
sexes should be considered as a key parameter in WBC protocols: females 
presented a 37% higher inner thermal resistance than males when reaching an 
asymptotical thermal state at rest due to higher concentration of body fat 
percentage. The authors of these studies agree that, in order to optimize 
treatment protocols, effects of sex and anthropometrics should be considered: 
in particular Polidori et al. (2018) suggested that the duration of cryotherapy 
protocols should be shorter when considering females compared to males.  
Despite the protocols utilized worldwide seems to be empirical and with a lack 
of scientific validation, WBC and PBC have demonstrated to  be a safe 
procedure and to confer benefits in most domains and not to induce negative 
general and specific effects. There are accepted contraindications for WBC, 
including cryoglobulinaemia, cold intolerance, Raynaud disease, 
hypothyroidism, acute respiratory system disorders, cardiovascular system 
diseases, sympathetic nervous system neuropathies and local blood flow 
disorders (Lombardi et al., 2017). Whole- and partial-body cryotherapy are 
generally considered procedures with few side effects, but there are no large 
studies that have established its safety profile: in a mindful review of literature 
we found six articles reporting adverse events after a single or multiple WBC 
sessions. Selfe and colleagues in 2014 excluded one Samoan rugby player with 
intolerance to ice packs which not disclose his cold intolerance to the study 
team. After undergoing a three minute WBC exposure he suffered a mild 
superficial skin burn bilaterally on the mid portion of the anterior thigh consisting 
of erythema and minor blistering approximately 2 cm high and 10 cm wide the 
day following WBC. In 2017 Carrard and colleagues reported a case of a 63-
year-old male who presented with transient global amnesia after undertaking a 
WBC session. As expected, the patient completely recovered in 24 hours but 
they firstly highlighted that WBC is potentially not as risk free as thought to be 
initially. In the same year Cámara-Lemarroy and colleagues in a case report 
referred of a 56-year-old patient who developed an abdominal aortic dissection 
after receiving a cycle of 15 sessions of WBC, suggesting that increase in blood 
pressure, heart rate and adrenergic response could have acted as a trigger for 
the onset of aortic dissections. Recently Greenwald and colleagues (2018) 
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reported a 47-year-old man after received 8 WBC treatment in two weeks was 
diagnosed of cold panniculitis based by his clinical presentation and histology 
(eruption, pruritus, pink papules and plaques, and a lymphohistiocytic infiltrate 
with neutrophils in the reticular dermis and superficial fat). Rivera and colleagues 
in 2018 in one patients discontinued the therapy after two sessions of partial-
body cryotherapy due to muscle stiffness and tremor. Finally Mackenzie 
O’Connor and colleagues in 2018 reported that a 71-year-old-man presented 
with a cold burn injury the day after his whole-body cryotherapy session maybe 
for a malfunctioned nozzle which sprayed liquid nitrogen directly on his back for 
a prolonged period (approximately 1 minute). These publications imply that 
further studies investigating the possible adverse events are required.  
 
2.3  MECHANISM OF ACTION OF WHOLE- AND PARTIAL-BODY 
CRYOTHERAPY 
 
The main effects of cryostimulation (Demoulin and Vanderthommen, 2012) are 
related to analgesia (gate control activation, lower nociceptor excitability 
thresholds and reduction in nerve conduction velocities), anti-inflammatory 
response (lower enzymatic activities, e.g., metalloproteinases, and decreas in 
production of pro-inflammatory mediators), lower levels of oxidative stress and 
decrease of edema and bleeding (lower vascular permeability and induced 
vasoconstriction).  
In order to understand the mechanism of the effects of WBC and PBC, results 
related responses to pain, stress and inflammation have been reported. 
Localized analgesia requires a skin temperature that is below 13.6°C, this is 
made possible by vasoconstriction and direct skin cooling by very cold air, and 
the explanation for this analgesic effect is the reduction in nerve conduction 
velocity and acetylcholine formation (Bugaj, 1975). As can be seen in the figure 
1 (Guillot et al., 2014), cryostimulation activates the autonomic nervous system 
(Mourot at al., 2007) and the release from efferent sympathetic neuron of 
acetylcholine that links a7nAchR receptor and noradrenaline that binds b2-
adrenoceptor. Cold exposure has an immunostimulating effect caused by an 
increase noradrenaline response which is dependent on the relationship 
between core temperature decrease and duration of exposure (Bettoni et al., 
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2013). ACh anThe d NA may inhibit NF-kB pathway (nuclear factor kappa-light-
chain-enhancer of activated B cells, a protein complex that controls transcription 
of DNA, cytokine production and cell survival) and its downstream effectors (pro-
inflammatory cytokines, ROS and adhesion molecule gene 
transcription)(Pournot et al., 2011). NA induces vasoconstriction through a-
adrenoceptor (Shepherd et al., 1983) which could limits inflammation and cold 
stimulus down-regulates and inhibits the enzymatic pathways involved in joint 
inflammation and destruction (Banfi et al., 2009). Cold application decreases the 
requests oxygen and ATP with an improvement in cell survival and diminished 
secondary hypoxic lesions (Guillot et al., 2014). 
WBC is comparable, to physical activity, at least in the pulsed, and temporarily 
limited, induction of pro-inflammatory cytokines and the induction of irisin 
expression, a myokine induced by exercise which activates oxygen 
consumption in fat cells and stimulating thermogenesis at the adipose tissue 
level (Dulian et al., 2015). This founding indicate that the sympathetic activation 
induced by the cryostimulation can be able to mimic physical activity (Lombardi 
et al., 2017). 
 
In conclusion, mechanisms of action of partial- and whole-body cryotherapy are 
not completely clear: further studies are needed to establish the causes of the 
main effects of these cryostimulation techniques.  
 
 
 
Figure 1: Proposed model of molecular pathways involved in cryotherapy (from Guillot et al., 
2014). 
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2.4 CIRCULATORY AND RESPIRATORY RESPONSES TO WHOLE- AND 
PARTIAL-BODY CRYOTHERAPY 
 
In accordance with scientific literature, it can be say that for a healthy individual, 
cryotherapy is to be considered as a safe method as regards the 
cardiorespiratory system, even if Càmara-Lemarroy and colleagues published 
in 2017 a paper reporting a cardiovascular complication associated with WBC. 
Many studies investigated the effects of whole- and partial body cryotherapy on 
heart rate, heart rate variability and blood pressure. For example Lubkowska 
and Szygula in 2010 evaluated changes in blood circulation and also aerobic 
capacity in healthy young men exposed to fifteen sessions of whole-body 
cryotherapy lasted three minutes at a temperature of -130°C, preceded by 30 
seconds of adaptation in a vestibule at -60°C. Authors tested blood pressure 
and heart rate before, immediately after and ten minutes after each WBC 
session. They calculated also pulse pressure and the mean arterial blood 
pressure, finding a significand increase in systolic blood pressure after each 
cryostimulation and a significant increase in diastolic blood pressure only after 
the first session. They also found a significant decrease in heart rate, without 
any adaptation changes after the cycle of ten consecutive sessions. This led 
them to consider whole-body cryotherapy a safe technique, but not 
recommended for those with advanced or not pharmacologically controlled 
hypertension. For their part Zalewski and colleagues (2013) in their research 
evaluated the complex hemodynamic physiological reactions in response to a 
three-minutes long session of whole-body cryotherapy with temperature set at -
120°C in thirty healthy subjects. They collected data at four time points: before 
cryostimulation, immediately after, three hours later and finally six hours later. 
They found a significant decrease of heart rate after whole-body cryotherapy 
exposure, but after three hours it returned to basal values and remained at the 
very similar level after six hours. This decrease could depend from two different 
mechanisms: the decrease in the sinoatrial node rate resulting from the inflow 
of cooled blood and for the enhanced parasympathetic stimulation, due to 
activation of baroreceptors and vagus nerve. Conversely beat-to-beat stroke 
volume and stroke index showed a significant increase immediately after cold-
exposure and returned to rest values after three and six hours respectively. 
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Regarding blood pressure parameters (systolic, diastolic and mean values) they 
found a slight increase after the whole-body cryotherapy session, although they 
not found significant changes from baseline. The scores of blood pressure 
parameters remained higher than baseline also after three and six hours 
respectively, however without reaching a significant statistical level. After one 
whole-body cryotherapy session they noticed also a significant increase of the 
baroceptor sensitivity, even if it decreased significantly both after three and six 
hours respectively: it could be a possible reason of the significant reduction of 
the heart rate and a non-significant increase of blood pressure, due to intense 
vasoconstriction which affect baroceptor sensitivity after several hours. They 
concluded that whole-body cryotherapy appears to be safe for healthy people, 
despite it strongly stimulates the baroreceptor cardiac reflex in response to body 
fluid changes which sequentially modulate heart rate and blood pression control. 
The same Polish group studied in 2014 (Zalewski et al., 2014) analyzed the 
heart rate variability and blood pressure variability, confirming the strong 
modulation of autonomic activity induced by a whole-body cryotherapy session. 
They found an increase in high-frequency component of the heart rate variability 
spectrum, corresponding to enhanced parasympathetic response, and a less 
pronounced increase of the low-frequency component. These changes were 
observed up to six hours after the cold exposure and were considered safety for 
healthy people. In another research, Cuttel and co-workers (Cuttel et al., 2017) 
investigated the effects of a single bout of whole-body cryotherapy (30 seconds 
at -60°C and 150 seconds at -110°C) on heart rate and blood pressure, 
examining the influence of sex and body composition. They found significant 
differences in mean arterial pressure between sexes both immediately after and 
after 35 minutes, with men showing higher values and no differences in heart 
rate between sexes after the WBC session. Regarding partial-body cryotherapy 
Louis and colleagues in 2015 verified the influence of exposing the head to the 
cold on the autonomic nervous system with a protocol including five consecutive 
cryotherapy sessions performed in two different systems: one exposing the 
whole-body to cold (cryochamber) and the other without exposing the head 
(cryocabin). Authors did not found significant changes in systolic and diastolic 
blood pressure after both cryostimulation techniques. They found that heart rate 
almost certainly decreased in both techniques with an higher bradycardia 
 23 
recorded after WBC than PBC, maybe explained by the additional stimulation of 
trigeminal cold receptors located in the face, and resting vagal-related heart rate 
variability indices (the root-mean square difference of successive normal R-R 
intervals and high frequency band) were increased after partial-body 
cryotherapy (+49.1% and +123.3% respectively) and whole-body cryotherapy 
(+38.8% and +70.3% respectively): suggesting that the magnitude of 
parasympathetic response to very low temperatures would be related to the 
magnitude of the cold stimulus and not to the head exposure to cold. Heart rate 
variability during the night was also assessed in a recent study (Douzi et al., 
2018) after an evening session of whole-body cryotherapy utilizing a recently 
validated (Bouzigon et al. 2017) cryochamber with technology based on forced 
convection (30 seconds at -25°C followed by 180 seconds at -40°C, with an 
average wind speed of 2.3 m s-1). They did not find significant differences for 
any parameter of heart rate variability recorded during the entire night sleep and 
the first 4-hour period. They found high-frequency bands significantly higher in 
the WBC group than in control group after the first ten-minutes long slow-wave 
sleep episode, and at the same time they found low frequency and the power 
ratio significant lower in WBC group than in control group, showing a greater 
parasympathetic and lower sympathetic activity during the slow-wave sleep 
episode following WBC. Finally, in 2014 I studied in person the effects of one 
single session of partial-body cryotherapy on cardio-vascular response (Fonda 
et al., 2014). The protocol consisted of four exposures of different duration (90, 
120, 150 and 180 seconds) in a cryocabin with temperature maintained between 
-130°C and -170°C. We found that different durations did not significantly affect 
the heart rate nor diastolic and systolic blood pressure responses. 
 
As can be seen, many authors found contradictory findings. These 
discrepancies could result from different methodologies of measurement, 
namely determining the cardiovascular parameters immediately after the 
exposure, when the response of participants was predominated by stress. 
Despite this lack in the standardization of measurements and of cold exposure 
parameters it can be assumed that whole- and partial-body cryotherapy are safe 
for healthy individuals and don’t induce long term adaptations in cardiovascular 
parameters. 
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Whole- and partial-body cryotherapy have been shown not to be deleterious 
also to lung function (Smolander et al., 2006): authors investigated the effects 
of repeated cold exposures (three times per week for twelve weeks) for two 
minutes in a temperature controlled unit set to -110°C. They measured the peak 
expiratory flow rate (PEF) and the forced expiratory volume in 1 second (FEV-
1) before and after two and thirty minutes respectively to the first whole-body 
cryotherapy session. They repeated the same measurements after 4, 8 and 12 
weeks. A sudden exposure to very cold environments may elicits several effects 
on the respiratory system, such as a gasp response, increase in ventilation and 
bronchoconstriction, but with repeated exposures they found that the peak 
expiratory flow rate and the forced expiratory volume in 1 second did not 
changed statistically significantly. In fact the PEF values did not changed 
between pre-exposure and after two minutes at any time of the study period, 
while after thirty minutes of the whole-body cryotherapy session they were 
slightly lower compared with pre-exposure values with a significant p value after 
one and three months respectively. No significant changes were reported at any 
time of the study period for the FEV-1 values: these results may depend from 
an airway acclimatization through habituation. Their findings indicated that 
whole-body cryotherapy is not harmful for lung function, inducing only minor 
bronchoconstriction in healthy individuals. In a recent study (Kojima et al., 2018) 
authors collected respiratory gas samples in young male athletes after an high-
intensity intermittent exercise, followed by a three-minutes long whole-body 
cryotherapy session (-140°C), determining oxygen uptake(V02), carbon dioxide 
output (VC02) and minute ventilation (VE) with an automatic gas analyzer. VC02 
and VE values were significantly lower in the whole-body cryotherapy group than 
in the control group approximately ten minutes after the cold exposure, reflecting 
a lower parasympathetic activity in the WBC group than in the control group. 
Finally in the above mentioned study, Lubkowska and Szygula in 2010, 
measured the VO2max in a population of normotensive, young and physically 
active men, involved in a protocol consisting of fifty sessions of whole-body 
cryotherapy, lasted three minutes each, with the temperature set to -130°C. 
Authors did not find changes in the level of aerobic capacity, in fact VO2max 
values showed a slight decrease after the treatment period, confirming the 
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founding of Klimek and co-workers (Klimek et al., 2010) which determined the 
influence of whole-body cryotherapy on aerobic and anaerobic capacities after 
ten sessions of cryogenic chamber treatment (180 seconds at -130°C). They did 
not find changes in aerobic capacity in the whole population after completing the 
ten sessions cycle and at the same time they found increase in maximal 
anaerobic power in males, but not in females, concluding that whole-body 
cryostimulation could be beneficial for increasing anaerobic capacity in 
sportsmen involving in sport disciplines characterized by speed and strength.  
 
Summarizing a single or a cycle of whole-body cryotherapy sessions does not 
be detrimental for the lung function or for aerobic or anaerobic capacity in 
healthy population, but should be applied with caution in susceptible individuals, 
such as asthmatics. 
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2.5  ADVANTAGES AND LIMITS 
 
Whole- and partial-body cryotherapy suit for the treatment of almost all known 
diseases connected with the immune system or metabolism disturbance, having 
a great positive remedial and normalization influence on them (Lubkowska et 
al., 2010a; Ziemann et al., 2013). Organism’s positive response to cryotherapy 
supports treatment of basic diseases and facilitates kinesitherapy. Cryotherapy 
represents a large wide of advantages: it takes short time for applying, being 
well tolerated by individuals and patients, and sportsmen status improves 
quickly. Athletes testimony is generally high and this contributes to develop cold-
treatments sometimes regardless of the underlying evidence. A wide range of 
positive cryotherapy effects is documented by many published researches and 
many of them are already unknown, or are not confirmed by the scientific 
community. For example in rehabilitative medicine whole- and partial-body 
cryotherapy are indicated for articular pain due to degenerative diseases 
(Hirvonen et al., 2006; Ma et al., 2013), low-back pain due to different etiology 
(Sliwinszki et al., 2017; Nugraha et al., 2015; Giemza et al., 2014; Giemza et al., 
2015), neck pain (Thomas et al., 2016), inflammatory pathologies of the muscle-
skeletal apparatus (Rose et al. 2017), psoriatic arthritis (Lange et al., 2008), 
rheumatoid arthritis (Gizinska et al. 2015); osteoarthritis (Chruściak, 2016), 
prevention of primary and secondary osteoporosis (Ksiezopolska-Pietrzak, 
1998; Galliera et al., 2013), fibromyalgia (Rivera et al., 2018; Vitenet et al., 2018; 
Bettoni et al., 2013), multiple sclerosis (Miller et al., 2011a; Miller et al., 2013; 
Miller et al. 2016; Pawik et al., 2019), anxious-depressive syndrome 
(Rymaszewska et al., 2008) and even mild cognitive impairments 
(Rymaszewska et al., 2018). However these studies are affected by several 
biases such as for example, as already discussed in this thesis, the lack of 
standardization of single- and multi-sessions cryostimulation protocols, no 
randomized controlled trial experiments and heterogeneous gender and 
anthropometrical characteristics within the study designs. These methodological 
shortcomings, in a scientific point of view, are the main limitation of cryotherapy 
techniques and it is required a scientific cooperation for building up standardized 
and safety protocols validated by wide and controlled studies. Bouzigon and co-
workers (2016) indicated as the first limit of these technologies the lacking in 
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available data concerning the actual temperature of exposure inside WBC 
chambers and PBC cryocabins: there is only one study (Savic et al., 2013) that 
showed a temperature of approximately -60°C rather than the expected -150°C 
inside a CryoMed cryocabin and no one about cryochambers. There are also 
other limits such as the practicality in terms of cost of each and multiple sessions 
(in Italy the range for a single PBC session varies from 30 to 70 euros) and in 
terms of access because these facilities are not located in all districts and during 
sport events, for example, the possibility of having one of these available is still 
too rare. In fact, with the exception of some models of PBC, these technologies 
are not mobile and even if they can be moved from place to place it must take 
into account that it is not possible to store nitrogen everywhere, because of the 
restrictive regulations for nitrogen storage. Another important limit of these 
technologies is the safety, first of all because of the direct contact with nitrogen 
inside cryocabins, and then because of the adverse events reported in literature. 
Another aspect linked with the safety limits is that the operators of cryotherapy 
facilities have not a standardized preparation (university career, specific training 
course, knowledge of scientific literature, etc.) so the practitioners tend to follow 
the crowd without examining the merits of these modalities: there are consistent 
difference between social and scientific proofs, that is why more researches are 
required in order to fully understand the potential benefits of whole- and partial-
body cryotherapy and, of course, every practitioners have to attempt to the 
scientific findings. 
 
2.6  STANDARD PROTOCOLS OF WHOLE- AND PARTIAL-BODY 
CRYOTHERAPY 
 
The number and the frequency of sessions that should be applied in order to 
obtain the best results for each individual are crucial topics which have been 
investigated by the scientific community in the last two decades. Right now there 
are not standardized protocols in the field of cryostimulation, neither for athletes, 
nor for patients and nor for healthy people. The dosage, in terms of frequency, 
temperature and time of exposure, are almost always decreed by the staff 
members of the cryotherapy facilities without any scientific support. In the last 
five years the growth of the cryotherapy market increased exponentially 
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worldwide, becoming a business trend: localized, whole- and partial-body 
cryotherapy are shifting from a medical treatment to a wellness routine, so the 
frequency of the cold exposures are more often decided by the possibilities, in 
terms of money and time, of the individuals instead of the protocols indicated in 
the scientific literature and this makes difficult to follow the indication of the 
literature slavishly. For example in their paper published in 2016, Giemza and 
colleagues stated that the common standard of ten sessions is insufficient, while 
at least twenty sessions of whole-body cryotherapy may efficiently enhance 
neuromuscular performance with an ability to sustain the improvements for at 
least three days. One year later, in the conclusions of their review also Lombardi 
and colleagues (2017) suggested that in the sports field a minimum of twenty 
consecutive sessions should be done for effectiveness evaluation and thirty 
sessions should be the optimum in the perspective of a complete hematological 
recovery after the initial response and Ksiezopolska-Pietrzak in 1998 suggested 
that to get the most benefits cryotherapy treatments need to be applied twice a 
day, with at least three hours interval and a kinesitherapy session after each 
cold exposure. 
 
Precisely, in literature can be found many researches with a specific proposed 
protocol based on different pathologies and purposes. 
 
In ankylosing spondylitis the effectiveness of whole-body cryotherapy has 
gained attention in the last year, with three published articles about this topic 
(Straburzynska-Lupa A., 2018; Stanek et al., 2018a; Stanek et al., 2018b). In 
2015 a study of Stanek and colleagues already showed the positive effects of 
ten consecutive whole-body cryotherapy sessions in patients suffering from 
ankylosing spondylitis. In this study the experimental group was exposed to ten 
three-minutes long whole body cryotherapy sessions once a day, followed by 
one hour of kinesiotherapy session. The researchers evaluated the answers of 
two questionnaires related to the pain intensity, stiffness degree, disease activity 
and functional scores. In addition they measured also spine mobility parameters 
both in the experimental group and in control group (which were exposed only 
to the one hour of kinesiotherapy). After the study period all measured 
parameters improved in each group, but changes in whole-body cryotherapy 
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group were significantly higher than in control group, demonstrating that a 
protocol of ten sessions in a row of WBC (duration of three minutes each and 
temperature ranging for -60°C seconds for the first 30 seconds and -120°C for 
the last 3 minutes) have a positive effects on the parameters of pain, stiffness, 
disease, functional scores indexes and spinal mobility parameters. The same 
author recently (Stanek et al., 2018a) estimated the impact of whole-body 
cryotherapy on cardiovascular risk factors in male patients with ankylosing 
spondylitis evaluating markers of inflammation, oxidative stress, lipid profile and 
atherosclerosis plaque. They compared the results of a control group 
(kinesiotherapy sessions only) with those of the WBC group (ten consecutive 
WBC sessions, which consists of 30 seconds in the antechamber with a 
temperature of -60°C and 3 minutes in the chamber where the temperature 
reached -120°C, followed by one hour of kinesiotherapy. They demonstrated 
that in the experimental group there was a decrease in oxidative stress markers 
and an higher differences in the total cholesterol, LDL cholesterol, triglycerides, 
s CD40L, PAPP-A and PLGF levels, suggesting that WBC could be a useful 
method of atherosclerosis prevention in patients with ankylosing spondylitis. The 
same authors (Stanek et al., 2018b) evaluated the routine parameters of 
oxidative stress in patients with ankylosing spondylitis utilizing the same 
standardized protocol of research in terms of randomization in the experimental 
and control group and in terms of cold exposure. They found a significant 
decrease of oxidative stress markers (total oxidative status and oxidative stress 
index) and a significant increase of total antioxidant status suggesting that a 
cycle of ten sessions of WBC performed in a closed cryochamber could be 
useful to decrease oxidative stress, in addition to pain, disease and stiffness 
indexes, in males suffering of an active phase of ankylosing spondylitis. Another 
polish group (Straburzynska-Lupa et al., 2018) evaluated the effects of three 
study procedures in 65 patients with ankylosing spondylitis: WBC at -110°C, 
WBC at -60°C and exercise therapy (control group). Two indexes of diseases 
activity (BASDAI and ASDAS-CRP) and biochemical parameters such as 
concentration of C-reactive protein (CRP) and the concentration of IL-8 and IL-
17 were measured at the beginning and at the end of the study period. They 
also studied the trend of the total antioxidant capacity and the thiobarbituric acid 
reactive substances (TBARS). In comparison to other groups, the group which 
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was exposed to the chamber set at -100°C had a significant increase in the 
concentration of TBARS. They also found a significantly lower BASDAI scores 
after ten consecutive sessions in the WBC at -110°C compared to the non-WBC 
group. The results of their study indicated that eight sessions of WBC at -110°C 
had a positive effect on lowering ankylosing spondylitis clinical activity as 
measured by the BASDAI.  
To the best of our knowledge, on the basis of the literature we can assume that 
an appropriate protocol for patients suffering from ankylosing spondylitis should 
be structured at least from eight to ten consecutive sessions of WBC with a 
temperature range at least from -110°C to -120°C. It’s however important to 
underline that neither of these studies considered a follow-up, so is not possible 
to know how the benefits last over time. 
 
Another kind of chronic pain disorder which gained the attention of the scientific 
community working on cryostimulation techniques is fibromyalgia. In the last 
year (2018) two studies documented the effects of whole- and partial-body 
cryotherapy in fibromyalgic patients. Ferrera and colleagues evaluated the 
efficacy of WBC for the control of pain and impact of disease by two indexes 
(Fibromyalgia Impact Questionnaire and Combined Index of Severity of 
Fibromyalgia). They enrolled 60 patients in a crossover study, treated on 
alternate days during three weeks with a three-minutes long partial-body 
cryotherapy session. After ten sessions, patients underwent a 1-week washout 
and subsequently they were inverted. They found positive effects of PBC after 
a cycle of ten sessions on ∆VAS pain, ∆FIQ and ∆ICAF scores, significantly 
higher than in control group. Recently also Vitenet and co-workers (2018) 
investigated about the effectiveness of whole-body cryotherapy on health-
reported quality of life assessment in fibromyalgic patients. They enrolled 24 
patients with fibromyalgia diagnosis randomizing them in two groups: the whole-
body cryotherapy group performed ten three-minutes long sessions at a 
temperature exposure of -110°C in a cryoair chamber (produced in Germany by 
Mecotec and cooled down electrically) whilst control group did not change 
anything in their everyday activities. Compared with the control group they found 
significant changes in WBC group in health-reported quality of life scores and 
they repeated the survey after a month showing that the positive effects lasted 
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for at least a month. Another study (Bettoni et al., 2013) demonstrated that 
fibromyalgic patients, after a cycle of 15 consecutive sessions (30 seconds at -
60°C and 3 minutes at -140°C), obtained significant improvement in health-
reported quality of life indexes compared to control group. For this study they 
used a cryo-chamber utilizing liquid nitrogen (they did not revealed the model).  
 
In conclusion we can summarize that a cycle of a minimum of ten consecutive 
sessions in PBC or in WBC should be recommended to fibromyalgic patients in 
order to improve quality of life parameters. The temperature of exposure should 
be lower than -100°C: this approach should guarantee maintenance of benefits 
for at least one month. 
 
Since its introduction whole-body cryotherapy was associated with the treatment 
of rheumatoid arthritis (Yamauchi, 1986). In the last years were published few 
researches about the effectiveness of the whole-body cryotherapy in patients 
with rheumatoid arthritis. In 2017 Hirvonen and colleagues measured the total 
radical-trapping antioxidant parameter TRAP, which reflects the global 
combined antioxidant capacity of all individual antioxidants in blood, in 60 
patients which was randomized I three groups: whole-body cryotherapy at -
110°C, whole-body cryotherapy at -60°C and local cryotherapy (cold air -30°C 
applied to five swollen joints at a time for 10-30 minutes). Each treatment was 
given three times a day for seven consecutive days. The results of this study 
indicated that whole-body cryotherapy at -110°C induced a short-term increase 
in TRAP during the first treatment session but not during other type of cold 
exposures, but this effect was short and the cold treatments did not cause 
significant oxidative stress or adaptations during one week. Another Finnish 
group of research (Hirvonen et al., 2006) compared two cold-exposure protocols 
in forty patients diagnosed with rheumatic arthritis: -60°C and -110°C 
cryotherapy sessions performed three times a day for a week for a total amount 
of twenty sessions. They found a more remarkable decrease in pain sensation 
and morning stiffness in the whole-body cryotherapy at -110°C than during other 
cryotherapies, but there were not significant differences in the disease activity 
between the groups. 
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In 2015 Gizinska and colleagues showed that after a cycle of ten three-minutes 
long cold exposures in a row at a temperature of -110°C, after passing through 
pre-chambers (-10°C and -60°C) there was a positive effect on patients with 
rheumatoid arthritis proven by a reduction in IL-6 and TNF-a. Moreover subjects 
involved in the experimental group improved pain, disease activity and fatigue 
scores, in addition to the time of walking and the number of steps over a distance 
of 50m. Similarly Jastrzabek and colleagues (2013) found consistent results on 
functional parameters and on decrease of TNF-a after a cycle of twenty three-
minutes long sessions performed in ten consecutive days of PBC (-160°C) and 
local cryotherapy (-30°C) with 20 patients diagnosed with rheumatoid arthritis 
randomized in each group. However, they did not find differences in the 
effectiveness of either cryotherapy.  
 
According to the literature whole- and partial-body cryotherapy have a positive 
effects on quality of life, physiological and performance scores in patients with 
rheumatoid arthritis. It seems not to be discriminating a lower value of 
temperature: a wide range such as from -60°C to -160°C should be effective for 
rheumatoid arthritis patients. It appeared that for this condition constancy is the 
key to obtain significant results in terms of pain (almost one week of twice daily 
sessions). As for ankylosing spondylitis neither of these studies considered a 
follow-up, so is not possible to know how the benefits last over time. 
 
In the last decade a Polish group driven by Elzbieta Miller has studied, with 
different research protocols, the effectiveness of whole-body cryotherapy in 
patients affected by multiple sclerosis (Miller et al., 2011; Miller et al., 2013; 
Miller et al., 2016). In their most recent study (Miller et al., 2016) they monitored 
the effects of whole-body cryotherapy on fatigue and functional status in multiple 
sclerosis patients with different levels of fatigue in two groups of subjects, the 
first one (n= 24) with a low fatigue score (measured with the Fatigue Severity 
Scale) and the second one with an high fatigue score. All multiple sclerosis 
patients involved in this study were exposed to ten consecutive whole-body 
cryotherapy sessions in a period of two weeks. Self-reported functional status 
indexes were assessed before and after the cycle of cryotherapy. They found 
significant improvements in both group after completing the treatment in the 
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functional status and in the feeling of fatigue, especially in the group with an high 
fatigue score. In another study (Miller et al., 2013) they investigated in a 
population of secondary progressive clinical form of multiple sclerosis patients 
the uric acid concentration and their functional state by means of the expanded 
disability status scales. They enrolled 22 patients and 22 healthy control 
individuals participating in a protocol of ten three-minutes long exposures of 
daily whole-body cryotherapy. They tested the subjects before the study period, 
immediately after and after one month and then after three months. They noticed 
that in the group of multiple sclerosis patients significantly increased the uric 
acid concentration in plasma both after ten sessions and after three months by 
the end of the study period. Their functional status improves after the study 
period and the positive changes in the expanded disability status scale 
maintained  a significant level also after one also after three months. In 
conclusion, they indicate that whole-body cryotherapy may be used as adjuvant 
therapy in secondary progressive multiple sclerosis patients. Miller and 
colleagues in 2011 compared the effects of ten consecutive exposures in a cryo-
chamber (with a temperature range of the main chamber between -110°C and -
160°C) on the total oxidative status (TAS) of plasma and activities of 
antioxidative enzymes in erythrocytes from depressive and non-depressive 
multiple sclerosis patients. They measured TAS, superoxide dismutase (SOD) 
and catalase (CAT) levels before and after the study period, founding an 
increase of the TAS level in depressive patients more than in non-depressive 
patients after a cycle of ten consecutive sessions of WBC. In their conclusions 
authors stated that a protocol of ten consecutive cold exposures in a 
cryochamber induced a suppression of oxidative stress in secondary 
progressive disease multiple sclerosis patients, especially in depressive ones. 
Recently Pawik and co-workers (2019) has studied the effectiveness of whole-
body cryotherapy and physical exercises on the psychological well-being of 
patients with multiple sclerosis. They enrolled 60 patients, who were divided into 
three groups: cryotherapy, physical exercise training and cryotherapy with 
physical exercise training. Participants who had WBC performed 10 sessions in 
a 2-week period. The temperature was maintained at -110°C during the first 
session and reached -160°C on the last day of the study. The physical exercise 
training lasted 60 min per session: after an initial warm-up, it consisted by 40 
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min of resistance exercises using the Thera-Band in closed kinetic chains. They 
measured well-being indexes by means of validated questionnaires such as The 
Psychological General Well-Being Index (PGWBI), Hospital Anxiety and 
Depression Scale /HADS) and the Rivermead Mobility Index (RMI). Authors find 
that the use of WBC reduced anxiety and depressive symptoms in studied 
patients with multiple sclerosis, particularly when combined with physical 
exercise training, concluding that the introduction of WBC into the standard 
physiotherapy protocol for patients with multiple sclerosis in fully justified. 
 
According to the literature, whole-body cryotherapy have a positive effect on 
oxidative stress, functional status and uric acid concentration in patients with 
multiple sclerosis. A minimum of ten consecutive sessions with a temperature 
of exposure between a range within -110°C and -160°C seems to ensure 
positive effects in multiple sclerosis patients. Benefits of the functional status 
can last up to three months, supportive even more the effectiveness of whole-
body cryotherapy in multiple sclerosis patients. 
 
Whole-body cryotherapy is often used as a symptomatic therapy against acute 
and chronic back pain: facilities working with cryotherapy chambers or cabins 
often promote the benefits of very cold exposures on pain relief in the low back. 
Few studies demonstrated the effectiveness of whole body cryotherapy on this 
musculoskeletal disease. For example Śliwinski and colleagues in 2017 
examined the differences of gender in two groups with low back pain about 
different etiology after a cycle of thirty interventions of whole-body cryotherapy 
followed by thirty minutes of kinesitherapy exercises. They utilized the VAS 
scale and the Schober test to evaluate the stepping of pain ailments and the 
mobility of lumbar spine respectively. They found significant improvements of 
the VAS score in men group, associated with an improvement in column mobility 
vertebral spine. However these improvements were not statistical significant in 
women group. In 2016 Nugraha and colleagues in a prospective randomized 
double blind study design evaluated the effects of ten consecutive sessions of 
whole-body cryotherapy at different temperatures: in fact one group was 
exposed to a temperature of -67°C and the other one was exposed to a 
temperature of -5°C. Authors evaluated the degree of low back pain by means 
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of self-related questionnaires such as Mainz Paing Staging System (MPSS), 
Pain Visual Analogue Scale (VAS), Pain Perception Scale (PPS), Pain Disability 
Index (PDI) and a self-designed patient questionnaire about subjective pain 
perception and general comfort. Their results showed that cold exposures to 
both temperatures could improve pain-related scores at the end of a cycle of ten 
consecutive cryochamber sessions. Their main founding was that was found the 
same effect from ten three-minutes long sessions at -67°C and at -5°C in a 
cryochamber for low back pain. Accordingly to these results they concluded that 
there is no need to treat patients with low back pain with very low temperatures 
(below -60°C). Concerning cold exposures and low back pain I was pleased to 
participate as co-author of a study (Giemza et al., 2015) in which we examined 
the differences in two groups of patients with low back pain of 40 subjects each. 
The first group performed two whole-body cryotherapy sessions a week, while 
the second group was exposed to WBC daily (from Monday to Friday), for a 
period of three week. The temperature of exposure was the same for each group 
and it was set to -60°C for the pre-chamber, where they spent a period of thirty 
seconds and then they moved in the main chamber, where they spent another 
three minutes, at a temperature of -120°C. We measured lumbar spine mobility 
with the assessment of active flexion and extension, rotation to the right and left, 
lateral flexion to both sides and the EMG measurement of erector spinae in the 
lumbar part of the spine performed at rest and in flexion, in adjunct to subjective 
parameters such as a pain scale (VAS) and functional limitations determined by 
the Activities of Daily Living survey (ADL). We found significantly lower values 
of active potentials of erector spinae muscles in the lumbar part of the spine and 
a significant increase in the range of the lumbar spine mobility only in the 
patients who was exposed to cryogenic temperatures five times a week for a 
total of fifteen sessions, concluding that only the regular application of WBC 
treatments is effective in pain reduction and mobility improvement in patients 
with low back pain. In a similar research, Giemza and colleagues (2014) studied 
the influence of WBC treatments on the improvement of spine activity in elderly 
men (age range 65-75 years). The protocol of cold exposure was the same to 
the study above mentioned in terms of number of sessions, temperature and 
time of exposure. Consequently, one group was exposed to fifteen WBC 
sessions and one group, as control, did not use whole-body cryotherapy. Mean 
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increase in the range of spine mobility was 69.06% for the WBC group while 
was only 21.26% in control group. The same results were found for muscle 
tension: a decrease of 59,25% for the experimental group while a lower increase 
(32.25%) in the control group. This induced the authors to state that, first of all 
whole-body cryotherapy is a safe procedure even to elderly people, and then is 
also effective in association with physiotherapy on people suffering from low 
back pain. 
 
WBC could be a useful treatment for low back pain, to improve range of motion 
and to decrease pain. The optimal protocol to achieve best results is debatable: 
it appears that a cold exposure at a temperature of -5°C could be enough to 
decrease pain. At the same time it is important that only the regular application 
of WBC treatments is effective because when the period between treatments is 
too long, positive results disappear and the procedures which occur next do not 
have a positive influence on a patient because they do not add up: that is why 
that ten consecutive daily sessions is the minimum gold standard to achieve 
best results. 
The areas of whole- and partial-body cryotherapy are varied, in fact in literature 
we can found also researches who have dealt the correlation with the exposure 
to very low temperatures to mental disorders, anxiety and depression. In a 
recent article (Rymaszewska et al., 2018) the authors evaluated the effects on 
cognitive functioning and blood parameters in 21 patients with mild cognitive 
impairments of a cycle of ten two-minutes long sessions of whole-body 
cryotherapy in a cryo-chamber cooled at a temperature between -110°C and -
160°C. Immediately after the last cryotherapy session and two weeks later, 
patients had improved significantly from baseline on two-word recall subscales 
of the DemTec, a psychometric screening tool, on the semantic and anterograde 
subscales of the 5-minute Test Your Memory (TYM) scale and on the logical 
memory subscale of the Saint Louis University Mental Status (SLUMS) exam. A 
cycle of ten WBC sessions induced also  a significant increase of nitric oxide 
(NO) plasma level, brain-derived neurotrophic factor (BDNF) concentration and 
reduction of interleukin-6 (IL-6). Their preliminary results suggested that a cycle 
of two minutes of daily whole-body cryotherapy sessions could be indicated as 
a supportive therapy in patients with mild cognitive disorders. Another Polish 
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group (Szcepanska-Gieracha et al., 2014) evaluated the impact of a cycle of ten 
whole-body cryotherapy exposures (from 1 to 2 minutes in the first two sessions 
to 3 minutes during the last eight sessions; they did not declared the temperature 
of exposure) on various parameters of mental state of the patients divided in two 
diagnostic groups (spinal pain syndromes and peripheral joint diseases). The 
patients completed a survey before the first treatment and after the last one. 
Results showed a significant improvement of the score of the administered 
questionnaires after the last session of WBC, having a significant impact on the 
improvement of patient’s well-being, mood and quality of life indices. No 
difference of age was noted, but a difference in gender was reported, with 
females having a more appreciable improvement than males. Better 
improvements were found also in the group with spinal pain and in which started 
the treatment period with more severe values of depressive symptoms. Finally 
in another paper (Rymaszewska et al., 2008) authors assessed the efficacy of 
whole-body cryotherapy in patients with anxiety disorders receiving standard 
psycho-pharmacotherapy. The experimental group received also fifteen 
consecutive whole-body cryotherapy sessions (duration from 2 minutes for the 
first visit to three minutes for the following and temperature -110°C for the first 
visited and then lowered to -160°C over successive visits). Depressive and 
anxiety levels was evaluated by the Hamilton’s depression rating scale (HDRS) 
and Hamilton’s anxiety rating scale (HARS). Authors found positive effects 
already after the first week of treatment and after three weeks these results were 
more consistent (34.6% of the study group decreased the HDRS scores more 
than 50% of the basal value and the 46.2% of the study group decreased of at 
least 50% from the baseline the HARS score). In the materials and methods 
section they stated to have measured these values also after three and six 
months respectively, but in this article they considered only the first three weeks 
of treatment. The findings of this study suggested that WBC could be an 
adjuvant treatment for mood and anxiety disorders in the short-term period. 
 
The mechanism of action of whole- and partial-body cryotherapy on mental 
state, anxiety, depression and mild cognitive disorders is not completely clear 
but its effectiveness is supported by few data. For sure, further and strongest 
researches are needed to comprehend the mechanism of action, the benefits 
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and their duration in the long-term of a cycle of whole-body cryotherapy in 
mental disorders. Protocols are vague and different from each study. A minimum 
of ten sessions is required with a duration lasting from 2 to 3 minutes and a 
temperature set from -110°C to -160°C: further researches are required to 
standardize the protocol in order to assist practitioners with patients with mental 
disorders. 
 
 
 
2.7  WHOLE- AND PARTIAL-BODY CRYOTHERAPY IN SPORT 
MEDICINE 
 
In the last decades whole- and partial-body cryotherapy modalities have been 
often utilized by athletes, trainers and sport physicians to promote enhanced 
athletic performance and recovery. It is thought that cryostimulation dampens 
the inflammatory response and reduces edema formation following strenuous 
exercise and the consequent exercise-induced muscle damage (EIMD). Current 
evidence supporting its utilization is limited and contradictory: athletes testimony 
is generally high, but it could be maybe induced by a possible placebo effect. 
Generally in literature, when authors tried to confirm the eventual benefits of 
whole- and partial-body cryotherapy on recovery or on athletic performance, 
they investigated the trend over time of the athletic performance by means of 
physical tests and the trend of indirect markers of muscle damage (creatine 
kinase, CK) and systemic markers of inflammatory response such as cortisol or 
cytokines (pro-inflammatory ones: interleukin-8 and -1b and tumor necrosis 
factor-a, TNF-a; anti-inflammatory ones: interleukin-10 and -1ra; and the 
inflammation regulator interleukin-6) 
In 2017 two review articles summarized the findings of literature about the 
utilization of whole-body cryotherapy as a recovery technique after exercise and 
its utilization in athletes population (Rose et al., 2017; Lombardi et al., 2017).  
In their interesting work, Rose and colleagues conducted a systematic search 
of the literature without restriction on the device utilized in the studies (WBC or 
PBC), on the duration, on the temperature of exposure, on the number and the 
frequency of the sessions and finally on the timing in relation to the exercise 
protocol administered. They evaluated only studies including a form of physical 
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exercise to induce muscle damage and an outcome measure associated with 
muscle damage including at least one measure between inflammatory markers, 
pain scores, muscle damage markers and sport performance or muscle function 
indicators. They included in their review 16 articles (Hausswirth et al.,2011; 
Pournot et al.,2011; Costello et al., 2012; Fonda et al., 2013; Mila-
Kierzenkowska et al., 2013; Ferreira-Junior et al., 2014a; Ziemann et al., 2014; 
Ferreira-Junior et al., 2015; Vieira et al. 2015; Krüger et al., 2015; Wozniak et 
al., 2007; Banfi et al.; 2009; Mila-Kierzenkowska et al., 2011; Ziemann et al. 
2012; Wozniak et al., 2013; Schaal et al., 2015), which were divided in two 
groups: the first one included researches with controlled damage protocol 
(Laboratory controlled studies, N=10) and the second one included researches 
with treatment proposed by means of routine training cycles, not standardized 
in terms of application and intensity of the stimulus, for all participants (Applied 
studies, N=6).  
In terms of standardization there were some differences between each 
proposed protocol: first of all they noticed that were recruited highly trained 
athletes in ten studies and in the remaining six articles were recruited healthy 
and physically active people. There were also numerous gender differences: two 
studies included only female participants, thirteen studies included only male 
participants and in the remaining one article were recruited both genders. In all 
studies participants were exposed to very low temperature for at least two 
minutes and for a maximum of three minutes. The number of cryostimulation 
sessions varied from one to thirty, performed in a range of one to ten days.  
In laboratory controlled studies, all four studies using multiple cryotherapy 
sessions found a significant decrease in muscle pain, associated with 
improvements in muscle function. Costello and colleagues (2012) did not find 
influence of a single WBC session on maximum voluntary contraction (MVC), 
but he administered cryostimulation only once and moreover 24 hours after the 
exercise inducing muscle damage. Also Vieira and colleagues (2015) did not 
found improvements in a performance test such as vertical jump: in this case 
they repeated the test very close to the cold exposure (30 minutes later) with a 
possible limited muscle functionality due to reduced muscle temperature. These 
two articles imply that the timing of whole-body cryostimulation could be a key 
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point in the validation and in the standardization of protocols aiming to enhance 
recovery and restore physical performance.  
Another crucial factor could be the total number of exposures to very-low 
temperatures during the recovery phase. This notion is supported by the 
analysis of circulating CK, a biomarkers of muscle damage. In one study 
(Ziemann et al., 2014) CK level in the experimental group (10 sessions in a 
period of five days) decreased significantly compared to the control group while 
in other two studies where researchers utilized a protocol of three (Hausswirth 
et al., 2011) and six (Fonda et al., 2013) cryostimulation sessions respectively 
no significant changes in CK scores were found. Finally, concerning the 
inflammatory response after very-low temperature exposures, the three study 
with standardized damage protocol that investigated levels of cytokines found 
similar results (Pournot et al., 2011; Mila-Kierzenkowska et al., 2013; Ziemann 
et al., 2014) with an increase of concentration of the anti-inflammatory cytokine 
IL-10, a drop of pro-inflammatory IL-6 concentration and a limited increase in IL-
1b concentration when participants were exposed to whole-body cryotherapy 
treatments.  
The authors of the review concluded that these findings suggest that whole-body 
cryotherapy may influence the pathways of inflammatory modulation, supporting 
the theory that WBC may prevent detrimental overexpression of inflammatory 
proteins.  
In applied studies, every single research used a protocol with more than a single 
WBC session: only one of these six studies found no significant results in 
inflammatory and damage markers (Mila-Kierzenkowska et al., 2011).  
Athletic performance, in terms of skill recovery after exercise, was investigated 
in two studies only and both of them found an improvement in performance in 
subjects involved in the experimental group: Ziemann and colleagues (2012) 
found improvements in tennis drills after a cycle of ten whole-body cryotherapy 
sessions (3 minutes; -120°C) performed in five consecutive days (twice a day) 
and Schaal and colleagues (2015) found a less remarkable reduction of the 
swim speed in a 400m trial in experimental group (ten sessions of WBC lasting 
three minutes at a temperature of -110°C) compared to control group.  
Concerning the applied studies, four of them founded a remarkable reduction in 
circulating CK levels and only one of them (Mila-Kierzenkowska et al., 2011) 
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found no significant difference in circulating CK concentration after a cycle of 
twenty WBC sessions (according to the original paper: two exposures a day for 
a period of ten days with a temperature range from -120°C to -140°C, while in 
the review authors wrote three exposures each day). In another study Banfi 
(Banfi et al., 2009) found  an increase of the anti-inflammatory cytokine IL-10 
after a week of typical training combined with daily WBC exposure (2 minutes at 
-110°C) in the Italian national rugby players. Finally in another study (Ziemann 
et al., 2012) authors found a significant decrease in TNF-a and an increase in 
IL-6 concentration after 10 WBC sessions after a study period of five days where 
international level tennis players combined low intensity training and cold 
exposures (twice a day). According to the 16 studies analyzed in this review, 
authors indicate that whole-body cryotherapy may be successful in enhancing 
MVC and returning athletes to pre-exercise strength at a faster rate than control 
conditions. WBC showed an analgesic response after damaging exercise, 
lowering pain scores on average 31% than control. 
 
Summarizing, Rose and colleagues suggested the utilization of WBC after 
exercise, taking in account a possible dose-response relationship between 
exposures with the recovery of muscle damage indicators. A minimum of three 
sessions, lasting three minutes are required. They have to be performed 
immediately after the strenuous exercise and in the two to three days post 
training. Cold exposure seems have no differences in term of efficacy if the 
temperature is colder than the average of -140°C. 
 
For their part, Lombardi and colleagues (2017) did not declare what kind of 
keywords they utilized for their review and neither the sources where they 
search for eligible papers, but they wrote an update of literature since the 
publication of their first review article concerning the topic of whole-body 
cryotherapy in athletes (Banfi et al., 2010). They analyzed the literature in order 
to discuss of the effects of whole-body cryotherapy (they did not take in account 
studied published on partial-body cryotherapy) on physiological and functional 
parameters.  
Concerning the hematological response to whole-body cryotherapy they 
analyzed articles which have studied erythrocytes and hemoglobin changes, 
 42 
iron metabolism, hemolysis, leukocytes and platelets levels. In one of the articles 
included in their review a group of 27 elite rugby players, which performed two 
daily sessions of whole-body cryotherapy in a whole week, showed a significant 
decrease of erythrocytes, hematocrit and hemoglobin (Lombardi et al., 2013) 
with a similar decrease of hemoglobinization reported by a previous article (Banfi 
et al., 2008). Also Szygula and colleagues (2014) reported a significant 
decrease in hemoglobin in a study performed of physically active subjects which 
underwent thirty whole-body cryotherapy sessions (3 minutes at -130°C) in a 
row. In this study hemoglobin remained lower than baseline until the twentieth 
session and it recovered during continued exposures after thirty sessions. A 
couple of studies (Ziemann et al., 2012; Sutkowy et al., 2014) did not find 
changes in hemoglobin and red blood cells in group of elite tennis players after 
a cycle of ten sessions of whole-body cryotherapy (twice a day for five days 
lasting three minutes at a temperature of -120°C) and in a group of kayakers 
after a cycle of twenty whole-body cryotherapy sessions (twice a day for ten 
days lasting three minutes at a temperature range of -120°C to -145°C) 
respectively. Lombardi and colleagues speculated that the shifts in hemoglobin 
and red blood cells counts induced by whole-body cryotherapy could depend on 
the sport discipline and individual baseline hematological profile. The 
phenomenon of the reduction of hemoglobin allows the whole-body cryotherapy 
to distance itself to any form of doping because the OFF-score, a parameter 
used to calculate the probability of blood doping in athletes, depends on 
hemoglobin concentration and Ret count (Lombardi et al., 2017). Moreover 
whole-body cryotherapy enhances hemolysis: a decrease of haptoglobin was 
described by Szygula and colleagues (2014). These findings are in contrast with 
those reported by Banfi and co-workers (2010) in their review analyzing data 
collected on rugby players after a whole week of whole-body cryotherapy 
treatments. Hemolysis stimulates the release of erythropoietin (EPO), as also 
documented by Szygula and colleagues (2014), with the aim to recover to 
baseline levels of red blood cells count and hemoglobin. The changes of EPO 
concentrations after thirty sessions of whole-body cryotherapy (temperature: -
130°C; treatment duration: 3 minutes) had a small, but statistically significant 
increase, stimulating erythropoiesis, which could facilitate a return of 
erythrocytic system indices to initial levels after the cold exposure cycle.  
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The above mentioned papers (Lombardi et al., 2013 and Sutkowy et al., 2014) 
demonstrated also that levels of leukocytes did not show any changes after a 
cycle of very-low temperature exposures (fourteen and twenty WBC sessions 
respectively), whilst Szygula and co-workers (2014) shown an increase of 
leukocytes after ten and twenty whole-body cryotherapy sessions in students of 
military academy, but recorded a return to baseline after thirty sessions: 
however these variations remained within the physiological range.  
Finally, platelet levels did not change after a cycle of whole-body cryotherapy 
sessions as reported by several articles (Lombardi et al., 2013; Ziemann et al., 
2014; Szygula et al., 2014).  
Concerning the lipids concentrations and the energy metabolism whole-body 
cryotherapy showed a dose-dependent response improving the lipid profile as 
already reported by Lubkowska and colleagues (2010c) in their study involving 
a group of professional rugby players and healthy individuals which performed 
from five to twenty WBC sessions daily. They found that five sessions are not 
enough to modify subjects’ lipid profile, while ten sessions induced a significant 
decrease in triglycerides and finally twenty sessions induced a decrease of 
triglycerides and low density lipoprotein cholesterol with an increase of high 
density lipoprotein cholesterol. These findings are consistent to those reported 
by Ziemann and colleagues (2014) after a cycle of ten whole-body cryotherapy 
sessions in a period of five days, where they reported a significant decrease of 
both total cholesterol and low density lipoprotein cholesterol values.  
In their studies on sportsmen the research group lead by Ziemann analyzed the 
trend of resting metabolic rate after very-low temperature exposures (Ziemann 
et al., 2012; Ziemann et al., 2014), in particular in professional tennis players 
exposed to ten WBC sessions, values of resting metabolic rate and of the 
percentage of fat used as a metabolic substrate did not change, as well for 
healthy, physically active men.  
Also bone metabolism was studied in professional athletes, in particular rugby 
players (Galliera et al., 2013), which underwent five consecutive two-minutes 
long whole-body cryotherapy sessions at a temperature of -120°C: the major 
findings of this research was an increase both of the osteoprotegerin (OPG) and 
consequently of the OPG/RANKL ratio, an index of reabsorption-to-formation 
balance, that could be have a beneficial role in the prevention of stress fractures. 
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In the field of sport recovery the anti-inflammatory effect of whole-body 
cryotherapy is the key factor of most of the studies. Lombardi and co-workers 
(2017) confirmed the results reported by Pournot et al., (2011), on the anti-
inflammatory markers such as IL-6 and IL-10 (which not changed after a three-
minutes long session whole-body cryotherapy at a temperature of -100°C), 
whilst it was noted a lower increase of the pro-inflammatory markers TNFa and 
IL-1b compared to the control group and a parallel inducing effect on the anti-
inflammatory IL-1ra one hour post-treatment, concluding that one session of 
WBC enhanced muscular recovery. Also the above mentioned paper, 
concerning the utilization of WBC in professional tennis players (Ziemann et al., 
2012), reported a more remarkable decrease of TNFa serum concentration in 
the experimental group compared to the untreated group. Also Mila-
Kierzenkowska and colleagues (2013) reported an anti-inflammatory response 
following a three-minutes long cold exposure at a temperature of -130°C with a 
prevention of the increase of IL-1b and IL-6 values. Selfe and colleagues (2014), 
for their part, reported that a single session of WBC performed at a temperature 
of -130°C did not affect IL-6 values in elite rugby players, no matter the duration 
of the treatment (lasted one, two or three minutes respectively). A single session 
of whole-body cryotherapy performed in a cryo-chamber for three minutes at a 
temperature of -110°C after an eccentric workout inducing delay onset muscle 
soreness (DOMS) in physically active young men increasing levels of IL-6, IL-b 
and IL-10 and thus mimicking the effects induced by strenuous exercise, while 
after ten sessions of whole-body cryotherapy performed in five consecutive 
days, a group of tennis players reported no significant changes for the values of 
IL-6 and IL-b and a significant increase of IL-10 compared to baseline (Ziemann 
et al., 2014). In conclusion, despite the fact that there are conflicting evidences 
in literature, it can be assumed that whole-body cryotherapy has an anti-
inflammatory response in athletes, with a similar trend of IL-6 compared to no 
cold exposure treatment after one session  and a faster recovery to baseline 
after several consecutive sessions. 
Concerning hormones profile an interesting article written by Grasso and 
colleagues (Grasso et al., 2014) evaluated the trend of elite rugby players during 
a whole week of training in which subject were exposed twice a day to a cryo-
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chamber sessions lasting three minutes each with a temperature of -140°C. 
They found a decrease of cortisol and dehydroepiandrosterone (DHEA) both 
after one and seven days. At the end of the study also estradiol decreased with 
a concomitant increase of testosterone level: this allowed to the testosterone-
to-cortisol ratio to increase, concluding that cryostimulation could potentially 
enhance the athletic performance. Nevertheless, it seems that the above 
mentioned article is the only one which reported a decrease of cortisol level after 
a cycle of whole-body cryotherapy. In fact, other studies found different results 
in the scores of this hormone: Ziemann and colleagues (2012) found an increase 
of cortisol after ten cryotherapy sessions (three minutes at -120°C) performed in 
a period of five days in professional tennis players, while testosterone was 
unchanged. Also in sixteen kayakers (Sutkowy et al., 2014), who underwent 
twenty consecutive whole body cryotherapy sessions in a period of ten days, 
levels of cortisol and testosterone remained unchanged. In a small group of elite 
rowers subjected to twelve whole-body cryotherapy sessions, lasting three 
minutes at a temperature range between -125°C and -150°C in a period of 
training of six days, cortisol levels registered an increase on the third day of 
study until it reduced its increase at the end of the study period (Wozniak et al., 
2013). Cortisol levels was unchanged also in a group of elite synchronized 
swimmers studied by Schaal and colleagues (2015) exposed to daily whole-
body cryotherapy sessions (3 minutes at -110°C) for a period of two weeks. 
Finally in a more recent study (Russel et al. 2017) there was no changes in 
cortisol levels after a single two minutes lasting very low-temperature exposure 
in a cryo-chamber set at a temperature of -135°C performed immediately after 
a repeated sprint exercise. 
In literature the effect on prooxidant-oxidant balance of whole-body cryotherapy 
was already studied in elite kayakers and in untrained men (Wozniak et al., 
2007) and it was confirmed by a more recent study from the same Polish 
research group (Wozniak et al., 2013) on elite rowers subjected to a period of 
training of six days combined with two daily whole-body cryotherapy sessions 
(three minutes at a temperature between -125°C and -150°C), where they found 
a lower activity of superoxide dismutase and glutathione peroxidase after the 
third day of training with WBC than without WBC. Also in another study 
performed in elite kayakers (Sutkowy et al., 2014) was assessed the efficacy of 
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the WBC on an oxidant-antioxidant balance, in which the efficiency of TBARS 
elimination increased after the end of a training period of ten days, combined 
with two daily cryostimulation treatments performed in a cryo-chamber at a 
temperature range from -120°C to -145°C. Summarizing the use of whole-body 
cryotherapy may reduce the risk of oxidative stress and the extent of muscle 
fiber injuries provoked by intense exercise, but it seems to have a dose-
dependent improving effect. 
Whole-body cryotherapy enhanced physiological and physichological recovery 
in nine endurance runners after performing a simulated trial run on a motorized 
treadmill in a study comparing three different recovery modalities (Hausswirth et 
al. 2011) in which the best results were observed after one hour, 24 h and 48h 
post-exercise in the WBC group. A possible explanation of the anti-inflammatory 
action of whole-body cryostimulation was also proposed by Ferreira-Junior and 
colleagues in 2014 (Ferreira-Junior et al., 2014b), suggesting the influence of 
WBC in inducing lower values of serum soluble intercellular adhesion molecule-
1 (sICAM-1) immediately after exercise induced muscular damage: this fact 
could be limit the migration of leukocytes from blood circulation to the damaged 
tissues. An interesting commentary on the above mentioned article was written 
by Benoit Dugué in 2015 explained that cold could induce an improvement of 
release of sICAM-1, leading a decrease of muscle inflammation: that is why 
Benoit stated there is for the time being no information available on the changes 
of sICAM-1 due the combine effects of EIMD and whole-body cryostimulation.  
Performance recovery, assessed with the time-to-exhaustion difference 
between a ramp-test protocol, was studied in  endurance athletes in the 
research performed by Krüger and co-workers (2015) after a single session of 
whole-body cryotherapy (three minutes at a temperature of -110°C) compared 
to a control group involving for the same time (three minutes) on a low intensity 
walk. Acute recovery was improved in the experimental group after high-
intensity intermittent exercise, might be induced by enhanced oxygenation of the 
working muscles, as well as a reduction in cardiovascular strain and increased 
work economy at submaximal intensities.  
For its part, Bleakley and colleagues, reported only little benefit towards 
functional recovery in their meta-analysis (Bleakley et al., 2014). They 
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speculated that less expensive cooling modalities should be used in order to 
obtain the same physiological effects of whole-body cryotherapy. 
 
Synthesizing the review of Lombardi and colleagues (2017), the WBC 
effectiveness of post-exercise recovery in athletes is evidenced by many articles 
even if, however, a small number of studies did not reported any positive effects.  
 
Analyzing the above mentioned reviews (Rose et al., 2017; Lombardi et al., 
2017), it is clear that WBC is an useful method for enhancing recovery, but is 
still to investigate if and how this treatment is better than other ones (also 
because the studies evaluating long-term WBC treatment were proposed during 
training and summer camps, and not during the season). Further researches are 
required for confirm the benefits of whole-body cryotherapy in population 
practicing sports, with wide and accurate studies.  
 
Whole- and partial-cryotherapy in the sport domains are utilized both by 
professional and recreational athletes. We cited in the above mentioned reviews 
only articles referred by the utilization of very-low temperature exposure by elite 
or professional athletes published before 2017. Noteworthy, there are many 
articles, which have investigated the utilization of whole- and partial-body 
cryotherapy also in recreational athletes or in healthy people aiming to evaluate 
their recovery after some bouts of proposed exercise. 
 
For example, recently a French group (Douzi et al., 2018) evaluated the effect 
of whole-body cryotherapy exposure in a cryo-chamber based on forced 
convection (three minutes at -40°C and a wind speed of 2.3 m s-1) after training 
in the evening on a group of physically active men. They examined the heart 
rate variability, as already reported in a previous paragraph, and the sleep 
quality, as a tool for measure the level of recovery. They proposed to the 
subjects involved in their study an evening training consisting of 25 minutes of 
continuous running at 65% of the maximal aerobic speed followed by intermittent 
running at 85% of the maximal aerobic speed and assigned them to very-low 
temperature exposure or to passive recovery in a random order. They found a 
significant decrease in the number of movements during the night following the 
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WBC exposure compared with the control condition. Also the subjective quality 
of sleep, measured with the Spiegel questionnaire was significantly better in the 
experimental condition than in the control condition. Finally the pain scores were 
significantly decreased following WBC compared to the control condition: that is 
why authors concluded that a three-minute single session of whole-body 
cryotherapy performed in a new kind of cryo-chamber based on forced 
convection (Bouzigon et al., 2017) in the evening improved the subjective and 
objective sleep quality in physically active men, enhancing the level of recovery. 
Interestingly few weeks before the publication of the above mentioned paper, 
another research was published about the use of cryostimulation as a recovery 
intervention in athletes (Wilson et al., 2018). Curiously also in this paper the 
protocol of exposure, in terms of time and temperature, was different compared 
to most of the articles (three minutes at a temperature range close to -130°C). 
In this protocol the experimental group was exposed to two cold treatments in a 
cryotherapy chamber, spending three minutes in the chamber set to -85°C and 
then having a fifteen minutes warming period in a temperature controlled room 
before entering for a further four minutes in the cryo-chamber at the temperature 
close to -85°C. Authors evaluated the perception of soreness and training 
stress, the markers of muscle function and inflammation and finally the efflux of 
intracellular proteins. These evaluation were done before and up to 72 hours 
post exercise. WBC at -85°C attenuated soreness after 24 hours and influenced 
positively peak force after 48 hours compared to cold water immersion (CWI, 
ten minutes in a mobile ice bath cooled to 10°C) and placebo (a cornstarch pill 
instead of branched chain amino acids), but many of the remaining outcomes 
were trivial even favorable to the placebo group. These findings let authors 
conclude that whole-body cryotherapy was not more effective than placebo 
treatment at accelerating recovery. Surely this study feeds the debate on the 
optimal protocol of exposure and also what are the optimal dosage and 
frequency of the cryogenic sessions. A plus point of this study was the insertion 
of the placebo group: in future studies about whole- and partial-body cryotherapy 
must have to take in account a placebo intervention. 
Another recent study (Krueger et al., 2018) investigated the acute effects of a 
single session of whole-body cryotherapy following severe intermittent running 
exercise on biomarkers of inflammation, muscle damage and stress involving in 
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a cross-over study eleven endurance-trained males. After an exhaustive 
intermittent running exercise subjects were exposed in a cryochamber for three 
minutes at a temperature of -110°C or to a passive control condition. Before and 
after one hour from the strenuous exercise a ramp test was completed and for 
seven time points up to 24 hours post exercise venous blood samples were 
analyzed for serum inflammation biomarkers evaluation. In their research they 
found that compared to the control group the whole-body cryotherapy did not 
attenuate exercise-induced changes in IL-6, IL-10, sICAM-1, myoglobin, 
cortisol, testosterone and their ratio. Accordingly, they stated that physiological 
mechanisms by which WBC is proposed to improve recovery may be inaccurate. 
In several paragraph of this thesis has been underlined that one single session 
should not be proposed as a recovery or anti-inflammatory protocol to achieve 
best results, that is why the aim of this above mentioned article seems not to 
provide a significant contribution to this topic and to the standardization of whole-
body cryostimulation protocols. 
Athletes were involved also in a recent study of a Japanese group (Kojima et 
al., 2018) in which the authors investigated the effect of a three-minute long 
whole-body cryotherapy treatment (-140°C) after an high-intensity treadmill 
exercise. After ten minutes following the completion of the exercise subjects 
were exposed to WBC or underwent a rest period (control group). Authors 
collected blood samples, respiratory gas parameters, skin temperature and 
ratings of subjective variables. Thirty minutes after the strenuous exercise ad 
libitum energy and macronutrient intake were evaluated during the buffet meal 
test, in which participants were instructed to “eat until they felt comfortable 
satiety”. Energy intake was calculated by measuring the weight of energy intake 
consumed. At the end of the study authors found a significant increase of energy 
intake level during the buffet meal test in WBC group than the Control group, 
concluding that a single very-low temperature exposure could increase energy 
intake in male athletes. Authors stated that increased energy intake following 
WBC may assist physical recovery, since insufficient energy intake during post-
exercise periods may delay recovery of muscle energy substance (e.g., muscle 
glycogen). 
Last year, another article about whole-body cryotherapy in endurance runners 
was published (Szymura et al., 2018), in which the effect of repeated whole-
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body cryotherapy sessions on the erythrocyte system in elder marathon runners, 
was studied and compared to untrained subjects. Master marathon runners and 
untrained subjects were exposed to twenty-four whole-body cryotherapy 
sessions (three minutes at a temperature to -130°C) performed every other day. 
Blood samples were taken before, at the half and at the end of the study, as well 
as one week after its conclusion. They showed that repeated cryostimulation 
sessions did not cause significant hemolytic blood changes in elderly men, 
despite of their fitness level. The protocol proposed did not increase the level of 
erythrocytes or their hemoglobinization: it could safely utilized also by elderly 
because it did not induced hemolytic anemia and, in case of athletes such as 
marathon runners, it can be assumed that WBC is not a form of doping. 
The topic of the utilization of WBC as a recovery technique in the sport field has 
been addressed also by Abaïdia and co-workers (2017) which compared the 
effects of cold-water immersion (ten minutes at 10°C) and whole-body 
cryotherapy (three minutes at -110°C) on recovery kinetics after exercise-
induced muscle damage. In a randomized crossover design they enrolled ten 
physically active men which performed 5 sets of 15 eccentric knee flexors 
contraction on one leg, after that they performed either a CWI or a WBC 
intervention. Authors evaluated the recovery level immediately after and 24, 48 
and 72 hours after the EIMD: they found a very like moderate effect in favor of 
CWI to improve recovery kinetics of single leg and 2-leg countermovement jump 
at the time point of 72 hours after the EIMD. Moreover CWI did lower ratings of 
muscle soreness and increase perceived recovery across 24-48 hours post-
exercise, these findings lead authors to conclude that CWI was more effective 
than WBC in accelerating recovery kinetics for CMJ performance at 72 hours 
post-exercise. In this study there was not a control group, so it is unknown if 
after an EIMD on a single leg WBC is useful to improve recovery in comparison 
with passive recovery. 
Another article published in the same year similarly evaluated the effects of a 
single whole-body cryotherapy (30 seconds at -60C followed by 120 seconds at 
-135°C) exposure on recovery levels after repeated sprint exercise in 
professional soccer players (Russel et al., 2017). Blood and saliva samples, as 
well as counter movement jump performance and perceived muscle soreness 
and recovery were assessed immediately, 2 hours and 24 hours after the 
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strenuous exercise. Authors found a greater testosterone response at 2 hours 
and 24 hours post exercise in WBC group than in control group, while other 
variables such as  peak power, CK, cortisol, testosterone/cortisol ratio, blood 
lactate, perceived soreness and recovery were not influenced by trial, but timing 
effects were significant with a subsequently returned to pre-exercise values 
within 2 hours. That is why they concluded that a single session of whole-body 
cryotherapy elicited greater testosterone concentrations for 24 hours after 
repeated sprint exercise when compared to rest and it could be linked to an 
attenuated inflammatory response to exercise, with possible implication for 
subsequent training motivation, indicating that WBC could be useful for soccer 
players’ recovery involved in close agonistic commitments. 
Finally in a Cochrane review Costello and colleagues (2016) examined the 
effects and safety of whole-body cryotherapy in alleviating DOMS after exercise 
in order to improve recovery. They found four eligible studies, but all of them 
had design features that carried a high risk of bias, thus limiting the reliability of 
the finding. Two studies used whole-body cryotherapy devices (specialized 
cryochamber set to a temperature of -110°C) and the other two used partial-
body cryotherapy in a special cryo-cabins (temperature between -140 and -
195°C). As the quality of the evidence was graded as a very low quality, authors 
assumed that a clinically meaningful was absent. That is why they did not 
supported the effectiveness in the reduction of muscles soreness and in the 
improvement of subjective recovery after exercise in physically active young 
men. Accordingly to their conclusions it is desirable to have high-quality and 
well-reported research on this topic. 
 
Most of the articles concerning the utilization of cryostimulation in the field of 
sport recovery were published utilizing whole-body cryotherapy devices and the 
minor part of them utilized partial-body cryotherapy devices. A study conducted 
with a partial-body cryotherapy technology was has been articulated by a 
Brazilian group (Ferreira-Junior et al., 2014c), which evaluated the effects of a 
single session of whole-body cryotherapy on neuromuscular performance, 
particularly on elbow flexor site. This study involved thirteen participants which 
were subjected to a partial-body cryotherapy session (3 minutes at -110°C, that 
is the most warm temperature ever published regarding PBC) or to a control 
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group. They were tested before and 10 minutes after each condition for their 
maximal isokinetic elbow flexion at 60°C. Authors did not find significant 
differences in peak torque, average power, total work or muscle activity between 
conditions. Thus it seemed that PBC exposure did not affect EMG signals of the 
elbow flexor, so authors concluded that partial-body cryotherapy could be 
utilized also before training or rehabilitation without compromising 
neuromuscular performance of the elbow flexors. 
Exposure to very-low temperature in cryo-cabin was recently studied also by 
another research group (Hohenauer et al., 2018) which compared the 
physiological responses and the effects on recovery following a EIMD on healthy 
males both after cold-water immersion and partial-body cryotherapy. 
Interestingly authors cited two works of mine when explaining the protocol 
utilized for very-low temperature (Fonda et al., 2014; De Nardi et al., 2015), but 
at the same time they utilized a protocol of cold exposure probably not 
reproducible with the device utilized for this study (Cryomed s.r.o., Cryosauna 
Space Cabin, Nové Zámky, Slowakia), that is 30 seconds of pre-cooling at -
60°C and then 2-minutes cooling at -135°C: for our best knowledge, and for my 
personal expertise in 7 years of utilization of the same device, is not possible to 
obtain a pre-cooling treatment at -60°C with the Space Cabin cryosauna model, 
and this is the only one study published with a pre-cooling exposure in a cryo-
cabin. Despite of this methodological issue, they analyzed the effects on 
physiological variables of the above mentioned two cooling modalities prior and 
up to 60 minutes post treatment, with an interval of 10 minutes between each 
measurement, and the effects on recovery variables prior and up to 72 hours 
post treatment, with an interval of 24 hours between each measurement. 
Authors did not find significant differences in DOMS between groups, also 
maximum voluntary contraction of the right knee extensor and vertical jump 
performance returned to baseline in both groups after 24 hours within no 
significant differences between groups. Concerning physiological response 
such as thigh muscle oxygen saturation and cutaneous vascular conductance 
CWI showed a greater impact than PBC, however both cold techniques showed 
similar recovery profiles during a 72-hours follow-up period. 
One of the most cited papers in the topic of recovery following PBC practice is 
that written by the Slovenian research team (Fonda and Sarabon, 2013), which 
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cooperated with me in the drafting of a couple of paper (Fonda et al., 2014; De 
Nardi et al., 2015), examining the effects of a five cryostimulation sessions 
lasting three minutes in a cryo-cabin at a temperature between -140 and -195°C 
in a 5-days period. They subjected participants to a bout of damaging exercise 
for the hamstring muscles on two occasions separated by 10 weeks (control and 
cold-exposure condition). Authors tested biochemical markers, perceived pain 
sensation and physical performance by means of squat jump test, counter 
movement jump test and maximal and explosive isometric torque production. 
Values of pain sensation tests differed statistically significantly between the 
control and PBC group 1-72 hours after exercise, with PBC condition showing 
lower pain values compared with control condition. Other interactions were not 
statistically significant, that is why authors did not provide conclusive support of 
the use of PBC for recovery enhancement after strenuous training. 
Finally, one of the few articles published utilizing PBC technology on the topic 
of the sport field, was that one I wrote in 2015 on the effects of PBC on flexibility 
(De Nardi et al., 2015). In a group of healthy people we evaluated the effects of 
a single partial-body cryotherapy session (150 seconds at a temperature 
between -130 and -160°C) by means of the sit-and-reach test. We evaluated the 
acute effect of a single very-low temperature exposure on the range of motion 
in men and women and we found a greater improvement of the sit-and-reach 
scores in the experimental groups compared to control groups, supporting the 
hypothesis that, after the decrease of neural activity due to cryostimulation which 
allows more elongation of the muscle at a given load, the range of motion is 
increased immediately after a single session performed in a cryo-cabin. These 
findings should encourage practitioners working with clientele aiming to increase 
range of motion to include PBC in their training periodization. 
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3. THE PURPOSE OF THE STUDY 
 
The general purpose of this thesis was to study possible practical applications 
of partial-body cryotherapy in the context of medicine, health and sport. 
More specifically, the aims of this thesis can be expressed as follows: 
 
a. To evaluate the acute effect of a single PBC session on maximum 
isometric strength, in healthy subjects;  
 
b. To evaluate the effects of repeated PBC sessions on pain threshold in 
healthy subjects; 
 
c. To evaluate the effects of repeated PBC sessions on quality of life in 
fibromyalgic patients. 
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4. ACUTE EFFECTS OF PARTIAL-BODY CRYOTHERAPY ON 
ISOMETRIC STRENGTH: MAXIMUM HANDGRIP STRENGTH 
EVALUATION. 
 
4.1  INTRODUCTION 
 
Muscle contraction is defined by the changes in length of the muscle during 
contraction: it can be classified into isotonic or isometric. Isometric contraction 
occurs when the muscle tenses while not changing its length. It is required in 
some sports (for example climbing and gymnastics) and physical and handwork 
activities. Many daily functions and sporting events require high activity levels of 
the flexor musculature of the forearms and hands. The most common method 
of assessment for grip strength is the use of a handheld dynamometer. This 
measurement may provide over all body strength and muscles performance, 
individual nutritional status and well-being, by a simple and non-invasive 
evaluation (Shea, 2007). It is known that temperature is a relevant determinant 
of muscles performance (Oksa et al. 1997; Ranatunga, 2010). Isotonic and 
isometric strength respond differently due a decrease in temperature (Sargeant, 
1987; Nodehi Moghadami et al, 2012). Some studies reported that cold 
application provides an effective way to increase isometric strength (Nodehi 
Moghadami et al, 2012; Burke et al., 2000). Human body responds to cold 
application with a vasoconstriction to maintain the core temperature. After this 
first response usually occurs the opposite phenomenon, a vasodilatation, which 
increase muscle blood flow with increased oxygen supply, therefore potentially 
improving muscle performance (De Ruiter et al. 1999). 
In the last decades, despite the increasing popularity of WBC in sports and 
exercise medicine, few studies have investigated the effectiveness of WBC on 
muscle-performance recovery after exercise in adults (Akehi et al., 2016; 
Costello et al., 2016), but till now no studies have examined the acute effects of 
cold on the maximum isometric strength. 
There are limited data about the effects of the cryogenic temperatures on 
isometric strength. Consequently, to evaluate the effects of a single PBC 
session performed before a maximum hand grip strength test, one hundred 
healthy men and one hundred healthy women were required to be present for 
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one time at the testing venue. Both men and women populations were divided 
in experimental and control group to assess the differences in maximum 
isometric strength after 150 seconds of standing rotations carried out in a cryo-
cabin or in a thermoneutral room. 
 
4.2  SUBJECTS 
 
The subjects were recruited to the study through announcements. All of them 
underwent a medical examination by a physician to avoid contraindications with 
exposure of extreme low temperature of partial-body cryotherapy. All of them 
had not practiced partial-body cryotherapy before. They was informed about all 
procedures and every step of the experimental protocol was explained before 
starting to collect data. A informed written consent form was fulfilled by the 
subjects before participating. All the procedures used complied with the 
principles of the Declaration of Helsinki. Table 1 shows the anthropometric 
characteristics of the subjects in this study. 
 
 
 Age (years) Height (cm) Weight (Kg) BMI 
(Kg/m2) 
(PBC-male, 
n=50) 
42.42±14.17 178.02±7.1 79.41±9.52 25.21±3.14 
(PBC-
female,n=50) 
41.26±11.73 165.0±5.1 62.0±7.95 22.79±2.79 
(CON-male, 
n=50) 
37.12±9.32 177.2±5.3 76.12±12.01 24.18±3.61 
(CON-female, 
n=50) 
39.56±11.38 167.12±6.2 64.94±7.79 23.38±3.03 
 
Table 1. Anthropometric characteristics of the subjects. Values are means ± SD.  
 
 
 
 
4.3  EXPERIMENTAL PROCEDURES 
 
Partial-body cryotherapy took place in a specially built, temperature-controlled 
cabin (Space Cabin, Criomed Ltd, Kherson, Ukraine), a single-user open tank 
equipped with a mobile lift, which allows to adjust the height of every subject. 
Thus each participant was exposed to the very cold dry air up to the shoulders, 
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with the neck and the head out of cabin. Every single session consisted of a 150 
s-long exposure at a temperature range between -130 and -160 °C (Fonda et 
al., 2014). During the session subjects wore swimwear, a pair of gloves, woolen 
socks and wooden clogs. Well instructed members of the cryotherapy studio 
was always present during the PBC sessions and instructed participants to turn 
around continuously in the cabin for each 150 s-long exposure session.  
Each subject enrolled in the experimental group was exposed once to PBC. On 
the other hand, each subject of the control group was asked to perform standing 
rotations for 150 seconds  in the turned off cryocabin (22.0±0.5°C). 
 
4.4  MAXIMAL HANDGRIP STRENGTH 
 
Maximal handgrip strength was recorded at two time points (T0 and T1) using a 
portable JAMAR Hydraulic Hand dynamometer (Sammons Preston Rolyan 
Nottinghamshire, United Kingdom). It was regulated for each subject fitting the 
hand and allowing flexion at the metacarpophalangeal joints. After completing 
individual adjustment operations each subject performed 3 submaximal 
voluntary isometric contractions maintained for 5 seconds as familiarization to 
the testing protocol. The scale of the dynamometer indicated handgrip strength 
in kilograms (kg). The testing protocol consisted of 3 maximal voluntary 
isometric contractions maintained for 5 seconds with rest period of at least 60 
seconds; the highest values was used for the determination of the maximal grip 
strength. Specific verbal instructions were given to subjects before the 
evaluations and the experiments were performed with verbal encouragement. 
Each group performed the baseline measurement (T0) and after the cryocabin 
treatment (T1 PBC) or control duty (T1 Control) repeated the maximal handgrip 
strength test. 
 
4.5  STATISTICAL METHODS 
 
The Statistical Package for the Social Sciences (SPSS) for windows (SPSS 
22.0, Inc., Chicago, IL, USA) was utilized. 
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A series of independent t-tests was used to control for any possible differences 
in the anthropometric characteristics and differences among handgrip strength 
values in both female and male PBC and control groups. 
A mixed-design repeated measures ANOVA was used to analyze handgrip 
strength values. Time (T0,T1) was the within-subjects factor, whereas Group 
(PBC and control) and Gender were the between-subjects factors. The 
probability level taken to indicate significance was p<0.05. Data are presented 
as means±SD. 
 
 
4.6  RESULTS 
 
 
PBC induced a significant increase of the maximum isometric strength both in 
males (T0: 50.75±8.77 kg; T1: 52.27±7.76 kg; p<0.01)  (Fig.2) and in females 
(T0: 28.47±4.45 kg; T1: 30.43±4.06 kg; p<0.0001) (Fig.3), whereas control 
group did not show significant changes. A high intraclass correlation emerged 
(ICC 0.987), (95% CI .975, .992) The results of the ANOVA showed a significant 
main effect of exercise (continuously standing rotations) in both groups 
(F1.196=45.59, P<0.05, η2=.189) on handgrip strength increase and a significant 
Exercise x Group interaction (F1.196=12.77, P<0.05, η2=.061). Both PBC and 
control groups showed an increase in handgrip strength values compared with 
T0 (T0=39.55 kg, T1=40.68 kg), in the experimental group (PBC: T0=39.61 kg, 
T1=41.34 kg) (Figure 4). The analysis reported also a significant effect of 
Gender (F1.196=491.99, P<0.05, η2=.715), with female participants showing 
lower handgrip strength values compared with male participants (females=30.43 
kg, males=52.27 kg).  
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Figure 2. Handgrip strength in male partial-body cryotherapy group (PBC) before (T0) and after 
(T1) cryotherapy session and in the control group (CTRL). **** p<0.01 
 
 
 
 
 
Figure 3. Handgrip strength in female partial-body cryotherapy group (PBC) before (T0) and 
after (T1) cryotherapy session and in the control group (CTRL). **** p<0.0001 
 
Males 
 
*** 
Females 
 
**** 
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Figure 4. Handgrip strength in female and male partial-body cryotherapy group (PBC)  before 
(T0) and after (T1) cryotherapy session and in the control group (CTRL). **** p<0.0001 
 
 
4.7   DISCUSSION 
 
In this study, the main finding was that maximal handgrip strength increased 
after a single session of partial-body cryotherapy lasting 150s. Because 
literature contains no reported data on isometric strength after a single PBC 
treatment, the findings of the present study can be compared with studies on 
cold therapy (cold water baths, ice packs). Our results confirmed that 
immediately after a PBC session there was a more remarkable increase in 
handgrip strength compared to baseline and to the control group. The results 
reported in the present study are in line with others that evaluated the effect of 
cold agents on the maximal isometric force (Burke et al., 2000; Nodehi 
Moghadami et al., 2012). In fact, 10 minutes of cold water bath provided an 
increase of the maximum isometric force production of the hip extensor 
significantly greater than that of the control and hot (43°C hot water bath) groups 
(Burke et al., 2000). Furthermore Burke and colleagues found a sex difference 
in the cold group, with men experiencing greater increases. Additionally, a 
Females + Males 
 
**** 
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previous study verified that after placing ice on the arm for 15 minutes 
significantly increased muscle force and, analogous to our findings, even for the 
control group there was a minimal increase in strength compared to baseline 
(Nodehi Moghadami et al., 2012). In our study we did not measure neither the 
muscle and skin temperature during or after a PBC session, but is known that 
skin temperature of the forearm is near to 23°C (Fonda et al., 2014). Therefore, 
it has been documented that a reduction on muscle temperature below the 
threshold of 27°C could decrease the maximal isometric force level (Clarke et 
al., 1962). Hence it would make sense, according to Westerlund and colleagues 
(2009), to assume that a single exposure in PBC does not lead to reach the 
threshold of 27°C for the muscle temperature, under which occur a decrease of 
the maximal isometric force level. To confirm this, immediately after a PBC 
exposure we noted an increase of the maximal hand grip strength, that may 
could be induced by the vasodilatation occurred after the PBC session, which 
determines an increased blood flow to muscles and, according with Nodehi 
Moghadami et Dehghane (2012), this may have a beneficial effect on muscle 
function. 
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5. EFFECTS OF PARTIAL–BODY CRYOTHERAPY ON 
PRESSURE PAIN THRESHOLD IN HEALTHY WOMEN 
 
5.1  INTRODUCTION 
 
In the last years pain management with cryostimulation technologies has been 
studied both in patients and in healthy subjects (Cholewka et al., 2006; Giemza 
et al., 2015; Costello et al., 2012). The most common approach to pain 
measurement in WBC and PBC studies is a participant self-assessment survey, 
using visual analog scale or other similar scales. Self-reported pain intensity is 
a combination of physiological and psychological aspects that can lead to a 
difficult interpretation of the results (Alonso-Perez et al., 2012). Indeed, it should 
be important to have pain measures that are not self-reported, in order to 
improve the assessment of the efficacy of the analgesic effects induced by cold 
agents. Pressure Pain Threshold (PPT) is defined as the least mechanical 
stimulus intensity at which a subject perceives pain (Vanderween et al., 1996). 
In literature Pressure Algometry (PA) performed with a handled algometer is a 
method extensively used to assess mechanical pain sensitivity in different body 
regions and to compare pain over time (Kardouni et al., 2015; Walton et al., 
2011; O’Neill et al., 2007).  
There are no peer-reviewed studies published on the evaluation of the effects 
of the PBC on PPT assessed by pressure algometry. Since PBC may play an 
important role in the pain management, the aim of this study was to investigate 
in a group of healthy women the effects induced on PPT by both one single 
session and a cycle of ten consecutive sessions of partial-body cryotherapy 
(PBC). 
 
5.2  SUBJECTS 
 
Thirty healthy women, naïve to the purpose of the experiment and in good 
health, were recruited for this study (Table 2). Inclusion criteria were the 
following: absence of pathology, injury, illness, chronic lower back pain and 
menstruation during the two-week trial. The exclusion criteria were 
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contraindications to cryotherapy and refusal to participate in the study. All 
participants never underwent to a PBC session before. They were instructed to 
refrain from consuming alcohol, caffeine, theine and hot drinks 24 hours before 
testing started, and to not take supplements or drugs during the study.  
They did not receive any incentive to participate in the study and they were free 
to leave the study before the end. All subjects signed an informed, written 
consent approved by the University’s ethic committee (Università degli Studi di 
Milano, n.9/15) and were examined by a qualified physician to exclude any 
contradictions to PBC. Subjects were randomly divided by use of computer-
based allocation into two age-matched groups: Partial-Body Cryotherapy group 
(PBC group, n=15, mean age±SD=46.07±11.40 years) and Control group 
(CTRL group, n=15, mean age±SD=45.79±7.83 years). All of them completed 
the entire protocol of the research.  
 
 
 
 Age (years) Height (cm) Weight (Kg) BMI (Kg/m2) 
(PBC, 
n=15) 
46.07±11.4 160.60±6.82 63.15±9.42 23.49±4.43 
(Con, n=15) 45.79±7.83 162.87±5.38 60.73±12.72 23.82±3.6 
 
Table 2  The anthropometric characteristics of the subjects involved in this study. Values are 
means ± SD. 
 
5.3  EXPERIMENTAL PROCEDURES 
 
In this study the subjects of the experimental group had 10 PBC exposures in a 
period of two weeks (performed every day from Monday to Friday). Partial-body 
cryotherapy took place in a specially built, temperature-controlled cabin (Space 
Cabin, Criomed Ltd, Kherson, Ukraine), a single-user open tank equipped with 
a mobile lift, which allows to adjust the height of every subject. Thus each 
participant was exposed to the very cold dry air up to the shoulders, with the 
neck and the head out of cabin. Every single session consisted of a 150 s-long 
exposure at a temperature range between -130 and -160 °C (Fonda et al., 2014). 
During the session subjects wore swimwear, a pair of gloves, woolen socks and 
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wooden clogs. Well instructed members of the cryotherapy studio was always 
present during the PBC sessions and instructed participants to turn around 
continuously in the cabin for each 150 s-long exposure session.  Each subject 
of the control group was asked to perform standing rotations for 150 seconds in 
the turned off cryocabin (22.0±0.5°C). The experimental protocol is summarized 
in Figure 5. 
 
 
 
 
 
Figure 5 Experimental protocol administered to the partial-body cryotherapy (PBC) group. In 
DAY 1, during the evaluation phase, the skin temperature and the pressure pain threshold were 
evaluated (Evaluation phase) before and after 1 cryotherapy session (Intervention phase), which 
lasted 150 s and during which the temperature ranged between -130 and -160 °C. From DAY 2 
to DAY 9 subjects participated to the Intervention phase. In DAY 10 they took part to the last 
cryotherapy session and the last Evaluation phase.  
 
5.4  SKIN TEMPERATURE 
 
Skin temperature was measured with noncontact, digital, infrared thermal 
camera (Flir C2, Flir System, Danderyd, Sweden) with an emissivity set to 0.98. 
Thermal images were analyzed with an appropriate software (Flir Tools+, Flir 
System, Danderyd, Sweden). Skin temperature was evaluated in the Control 
group in day1 and in the PBC group before and after the first and the tenth PBC 
sessions (baseline, pre1, post1, post10). 
 
5.5  PRESSURE-PAIN THRESHOLD 
 
A pressure algometer, with 1cm diameter hard rubber disk (Wagner pain test, 
Wagner Instruments, Greenwich, USA), was used to evaluate pressure-pain 
threshold (PPT). Before starting the experiment, in order to familiarize with the 
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algometer, the experimenter applied the instrument on the tibialis anterior of the 
subject. After this familiarization procedure, subjects laid down comfortably in a 
prone position, in a controlled temperature and soundproof room and were 
instructed to say “stop” when a sensation of pain occurred. Pressure was applied 
perpendicularly to the skin at constant speed (5 N/s) by the examiner, who 
performed one single measurement for subject. All measurements were taken 
by one examiner. In the PBC group measurements of PPT were conducted 
before (baseline) and immediately after the first PBC session (day1), and after 
the tenth PBC session (day10). In the Control group PPT was evaluated at 
baseline and at day10 (De Nardi et al., 2017). 
 
5.6  STATISTICAL METHODS 
 
The probability level taken to indicate significance was p<0.05, values were 
expressed as means ± SE. Variables were normally distributed according to the 
Shapiro-Wilk test. A t-test was use to compare skin temperature of the two 
groups at baseline in order to check for possible a difference between the two 
groups. Furthermore, in the PBC group skin temperature variations were 
evaluated before and after the first and the tenth sessions by means of a 
repeated measure ANOVA with SESSION (2 levels, day1 and day10) and TIME 
(baseline/pre10 vs. post1/post10), as within subjects factor.  
In order to test for possible modifications of the PPT values after the PBC 
sessions with respect to no intervention, a repeated measure ANOVA with TIME 
(2 levels, baseline and day10), as within subject factor, and GROUP (2 levels, 
PBC group and CTRL group), as between subject factor, was applied on PPT 
data. In order to evaluate the short- and long-term effect of PBC protocol 
administration, in the PBC group PPT values acquired before (baseline), 
immediately after the first PBC session (day1) and after the tenth PBC session 
(day10) were statistically evaluated by means of a one-way ANOVA. Newman-
Keuls post hoc comparisons were applied to assess significant interactions. All 
statistical analyses were performed using Statistica 13.0. 
 
 
 
 66 
5.7  RESULTS 
 
The skin temperature of the two groups at baseline was statistically comparable, 
as shown by the result of the t-test (PBC: 34.06±0.29 °C; CTRL: 34.78±0.29 °C; 
t=-1.79, p=0.09). The statistical analysis on skin temperature of the low-back 
region measured on subjects of the PBC group showed a significant effect of 
the factor  TIME (F(1,14)=519.47, p<0. 001 η2=0.97), and a significant decrease 
of skin temperature occurred after both PBC sessions (post1: 25.06±0.51 °C; 
pre1: 34.32±0.19 °C; post 10: 25.65±0.47 °C) (Figure 6). No frostbite was found 
during and after PBC. 
 
 
Figure 6. Mean skin temperature on the low-back region in subjects of the PBC group before 
partial-body cryotherapy (pre) and after partial-body-cryotherapy session (post) p<0.001. 
 
The values of the pain threshold assessed in the PBC group and in the CTRL 
group during the evaluations at baseline and at day10 are represented in Figure 
7. The results of the statistical analysis showed a significant interaction between 
TIME and GROUP (F(1,28)=11.82, p=0.002 η2=0.30). No differences were 
found between the two groups during the baseline evaluation (PBC group: 
84.53±7.89 N; CTRL group: 104.89±7.89 N; p=0.27). In the PBC group post hoc 
tests revealed a significant increase of the pain threshold from baseline to day10 
(day10: 110.01±6.39 N; baseline vs. day10: p=0.002), whilst no differences 
between baseline and day10 appeared in the CTRL group (day10: 99.47±6.39 
N; baseline vs. day10: p=0.39). 
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Figure 7 Values of pain-pressure threshold (N) for the two groups (PBC: partial-body 
cryotherapy; CTRL: control group) in different evaluation epochs (baseline: before intervention; 
day 10: after the last PBC session).**p=0.002. 
 
 
 
Figure 8 shows pain threshold values of the PBC group at different time points: 
baseline, after the first (day1) and the last (day10) cryotherapy session. The 
results of the one-way ANOVA showed a significant effect of the factor TIME 
(F(2,28)=6.63, p=0.004 η2=0.32). Newman-Keuls post hoc comparisons showed 
a significant increase of the pain threshold in day10 with respect to baseline 
(day10 vs. baseline: p=0.003) and day1 (day1: 96.06±9.68 N; day10 vs. day1: 
p=0.04).    
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Figure 8  Mean pressure pain threshold (PPT, N) values evaluated in the partial-body 
cryotherapy group. Measurements were obtained at baseline, after the first cryotherapy 
session in DAY 1 and after the last cryotherapy session in DAY 10. Error bars represent the 
standard error. * and ** refer to p<0.05 and p<0.01, respectively.  
 
 
5.8  DISCUSSION 
 
In this study, we assessed the effects of our protocol of partial-body cryotherapy 
(duration: 150s; temperature range: -130 ÷ -160°C) on mean skin temperature, 
pre- and post-PBC exposure, measured by thermal imaging. Indeed, under our 
experimental conditions, the calculated variations in mean skin temperature on 
the low-back region was -8.84±1.8°C, with a statistically significant difference 
between pre- and post-PBC value. These values are in agreement with those 
reported by Bouzigon and co-workers (2016). For our study we involved only 
female participants. For its part, one study have investigated the role of sex 
difference on mean skin temperature following whole-body cryotherapy, and, 
even if the reported findings must be interpreted with caution as also suggested 
by the Authors, this study showed that female participants experienced a greater 
reduction in skin temperature than males (Cuttel et al. 2017). An objective 
method to calculate the cooling rate of the skin such as thermal imaging 
(Costello et al., 2012) is a key index in the evaluating the analgesic effects of 
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whole- and partial-body cryotherapy, that is why it should be included in every 
further research on this topic. 
In this study we also tested the effects induced in healthy women on PPT via 
pressure algometry by both one single session and a cycle of ten consecutive 
sessions of partial-body cryotherapy. We found that healthy women involved in 
a cycle of 10 sessions of PBC showed significantly higher PPT scores after the 
tenth PBC session compared to those obtained either after one single session 
or in Control group. Consequently one single session of partial-body cryotherapy 
did not demonstrate to be enough to increase significantly pain threshold in 
healthy women. 
Pressure algometry has been shown to be a non-invasive, efficient and reliable 
method in the study of pathophysiological mechanisms involved in pain and 
pressure-pain algometric measurements have been demonstrated to provide 
reliable data on PPT measures obtained in healthy subjects also on consecutive 
days (Nussbaum and Downes, 1998). Reliability is enhanced when all 
measurements are taken, as in our study, by one examiner. 
To the best of our knowledge there are no papers in literature that have 
examined directly the pain threshold by means of a direct measurement. 
However our results are in line with those of the Authors who have investigate 
the pain trend after a single session of whole- or partial-body cryotherapy 
utilizing self-related questionnaires. For example Hohenauer and colleagues 
(2018) did not found reduction in pain scores after a muscle-damaging protocol 
followed by a single session of partial-body cryotherapy. 
On the other hand, after a cycle of ten sessions of PBC we found that healthy 
women showed significantly higher PPT scores after the tenth PBC session 
compared to those obtained either after one single session or in Control group. 
These results are in agreement with previous reports on the analgesic effects of 
systemic cryotherapy (Cholewka et al., 2006 ,Giemza et al., 2015, Bettoni et al., 
2013). 
The analgesic effect of cooling therapies could be due to many mechanisms, 
including reduced nervous conduction velocity, inhibition of nociceptors, 
reduction of metabolic enzyme activity levels. Moreover, cryotherapy could also 
be effective in pain management via diffused noxious inhibitory controls, pain 
gait theory, decreased nociceptive receptors sensitivity, or via analgesic 
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descending pathways from central nervous system, with release of endogenous 
opioids, such as endorphins (Saeki, 2002). 
Any specific hypothesis on mechanisms leading to the increase in PPT observed 
in our study with cryotherapy is purely speculative. However, this study was 
limited to subjects without established pain syndromes and the participants were 
submitted to a pain-induction procedure. Therefore, we can focus only on some 
of the above mentioned putative mechanisms to explain the analgesic effects 
we observed. On this basis, one plausible hypothesis is that in our study 
cryotherapy could have exerted its effect on pain through a decrease in nerve 
conduction velocity (NCV). NCV can be affected by gender, age, and, more 
pertinently, skin temperature (Binnie et al., 1995). A previous study showed that 
cryotherapy, performed by ice application, increased PPT in adult male sports 
players and this effect was associated with a significant decrease in NCV 
(Algafly and George, 2007). On the basis of the literature, two possible 
mechanisms could be take in account for the effect of cryotherapy on NCV. A 
previous research has suggested that temperature can affects the exchange 
between Ca2+ and Na+ in neural cells (Reid et al., 2002). Indeed, these Authors 
reported that low temperature could increase the friction between Ca2+ and its 
cellular gates during ionic exchange, that could result in the delay of action 
potential generation. A second mechanism refers to the increased sympathetic 
adrenergic activity, induced by the exposure to extreme cold, causing 
constriction of arterioles and veins and, as a consequence, reducing nerve 
conduction velocity (Herrera et al, 2010). 
Indeed, the demonstrated significant reduction in mean skin temperature could 
have led to a strong stimulation of cutaneous thermoreceptors and, as a 
consequence, to activation of thermoregulation hypothalamic center, with 
excitation of sympathetic adrenergic fibers. The stimulation of the sympathetic 
system, the release of noradrenaline and the vasoconstriction may also have 
induced other significant effects on pain management. It has been demonstrated 
that noradrenaline spinal administration in animals as well as epidural injections 
of adrenergic agonists in humans alleviate pain (Pertovaara and Kalmari, 2003; 
Gordh, 1988). Moreover, an increased release in noradrenaline reaching, via 
the posterior spinal arteries, the substantia gelatinosa in the spinal cord, where 
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pain afferents from skin terminate, may be involved in mechanisms, that reduce 
pain transmission at the spinal level (Bouzigon et al., 2016). 
In physical exercise, the exposure of skin and muscles to extreme cold 
temperatures may also lower enzyme activities and metabolism by inducing the 
peripheral vasoconstriction that reduces peripheral blood flow by attenuating 
inflammatory response and limit protein degradation, which can be important 
features of recovery improvement (Banfi et al, 2009; Bouzigon et al., 2016). 
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6. EFFECTS OF PARTIAL-BODY CRYOTHERAPY ON PERCEIVED 
HEALTH AND QUALITY OF LIFE OF FIBROMYALGIC PATIENTS 
 
6.1  INTRODUCTION 
 
Fibromyalgia (FM) is a widespread pain disorder, characterized by neurological 
pain, fatigue, arthralgias, stiffness, sleep disturbances, and other frequent 
physical and mental disorders (Borchers et Gershwin, 2015). The neurologic 
origin of pain has been attributed to an imbalance in the levels of pro- and anti-
inflammatory mediators and to an impaired central processing of painful stimuli 
(Sluka et Clauw, 2016). FM patients often report additional somatic and 
psychological symptoms to different degrees, which may change over time and 
with treatment (Clauw et al., 2003). FM is associated with central nervous 
system aberrance, such as alteration of sensory processing in the brain, 
reduced reactivity of the hypotalamus-pituitary-adrenal axis to stress 
(Wingenfeld et al, 2010), increased pro-inflammatory and reduced anti-
inflammatory cytokine profile (Rodriguez-Pintó et al., 2014) and disturbances in 
neurotransmitters, such as dopamine and serotonin. Females are affected at 
least 6 times more often than males (Branco et al., 2009).  
Research has not found effective therapies for FM, and long-term follow-ups 
demonstrate that FM remains chronic, with scarce probability of full recovery 
(Isomeri et al, 2018). Recently, accepted treatment modalities of FM have 
shifted significantly from a pharmacologic therapy alone to a systematic 
multimodal approach. Therapies that focus on restoring sleep quality and 
reducing anxiety and stress have shown encouraging results as well as low 
intensity aerobic exercise (Ellingson et al., 2016) seems to prove an effective 
alternative to drugs. Recent studies have shown that whole body cryotherapy 
(WBC) can improve health-reported quality of life on fibromyalgic patients 
(Bettoni et al., 2013, Vitenet et al., 2018). However, only few studies were 
published on the effectiveness of WBC on parameters of wellbeing and quality 
of life in fibromyalgic patients (Bettoni et al., 2013, Vitenet et al., 2018). In the 
above mentioned studies the authors found beneficial effects on health-reported 
quality of life in patients with FM utilizing WBC technologies. However there are 
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no data in literature about the effect of PBC on perceived health and quality of 
life indexes in patients affected by FM. 
The aim of the present study was to investigate the effects of PBC on the 
perceived health and quality of life in fibromyalgic patients. 
 
 
6.2  SUBJECTS 
 
Twenty-eight female participants were recruited for this study. The inclusion 
criteria were to be adult and clinically diagnosed with Fibromyalgia using the 
American College of Rheumatology’ standard criteria (Wolfe et al., 2010). All 
volunteers underwent an initial physical examination by a qualified physician to 
avoid contradictions to PBC. They did not receive any incentive to participate in 
the study and they were free to leave the study before the end. The research 
was undertaken in compliance with the Helsinki Declaration and each participant 
signed an informed consent in which  risks and procedures of the study were 
exhaustively explained. During the two week observation they were asked to not 
modify pharmacologic treatments they were subjected to prior to the study. 
Subjects were all not accustomed to PBC treatment. Subject were randomly 
divided into a partial body cryotherapy group (n=14; age: 46,31±10,02; PBC 
group) and control group (n=14; age: 47,36±7,53). All of them completed the 
entire protocol of the research and also fulfilled the final survey. Socio-
demographic information for each group is shown in Table 3.  
 
 Age (years) Height (cm) Weight (Kg) BMI (Kg/m2) 
(PBC, 
n=14) 
46.31±10.02 164.46±7.03 66.08±13.91 24.51±4.47 
(Con, 
n=14) 
47.36±7.53 161.53±6.12 62.29±11.21 23.99±3.79 
 
Table 3. The anthropometric characteristics of the subjects involved in this study. Values are 
represented as means ± SD. All participants were female. 
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6.3  EXPERIMENTAL PROCEDURES 
 
The subjects in the partial body cryotherapy group completed ten consecutive 
treatments, performed in two weeks, in a cryocabin (Space Cabin, Criomed Ltd, 
Kherson, Ukraine). Every single session consisted of a 150 s-long exposure at 
a temperature range between -130 and -160 °C (Fonda et al., 2014). During the 
session subjects wore swimwear, a pair of gloves, woollen socks and wooden 
clogs. Well instructed members of the cryotherapy studio was always present 
during the PBC sessions and instructed participants to turn around continuously 
in the cabin for each 150 s-long exposure session. All subjects kept their 
prescribed pharmacological therapy and their everyday activities.  
 
6.4  SELF REPORTED QUALITY OF LIFE 
 
All subjects filled out a questionnaire at two time points – before the start of the 
study (T0) and at the end of the treatment (T1). The Psychological General Well-
Being Index (PGWBI) and the VASFIQ were utilized in this study. The PGWBI 
questionnaire consists of 22 items and it is designed to assess the subjective 
representations of intrapersonal affective or emotional states reflecting the level 
of well-being or distress. This survey evaluates six dimensions: anxiety, 
depression, well-being, self-control, general health, and vitality. The maximum 
score of each element is 5 points. The VASFIQ is a seven-item scale composed 
of Fibromyalgia Impact Questionnaire (FIQ) and Visual Analog Scales (VASs) 
designed to quantify global fibromyalgia severity and identify seven symptoms 
widely regarded as clinically relevant to patients with FM such as pain, fatigue, 
poor sleep, work-related pain, stifness, anxiety and depression. Each item is 
rated on a scale ranging from 0 to 10. A high score is indicative of a high degree 
of patients’ disease. 
 
6.5  STATISTICAL METHODS 
 
Statistical analysis were performed on the results of PGWBI and VASFIQ as a 
whole and on each domain. In particular, a repeated-measure analysis of 
variance (RM-ANOVA) was applied on PGWBI, with TIME (2 levels, PRE and 
 75 
POST) as within subject factor, and GROUP (2 levels, PBC and Control) as 
between subject factor. The same RM-ANOVAs were applied also on the 
PGWBI domains whose data resulted to be normally distributed, namely anxiety, 
well-being, self-control, general health, and vitality. Significant interactions were 
interpreted with Newman-Keuls post hoc comparison. Since the scores of the 
depression domain were not normally distributed the comparison within each 
group (PRE vs. POST) was done by means of Wilcoxon test, and the 
comparison between each group in each evaluation epoch was done by means 
of Mann-Whitney tests. VASFIQ scores were not normally distributed, both as a 
whole and in each domain. For this reason the comparison within each group 
(PRE vs. POST) was done by means of Wilcoxon test, and the comparison 
between each group in each evaluation epoch was done by means of Mann-
Whitney tests. All statistical analyses were performed using Statistica 13.0. Data 
are means±SE. 
 
 
6.6  RESULTS 
 
The results of ANOVA on PGWBI (fig. 9) showed a significant GROUP*TIME 
interaction (F(1,26)=59.29, p<0.001). Post hoc analyses revealed that the two 
groups did not differed at baseline, whilst PGWBI at POST of PBC group was 
significantly higher than that of the CONTROL group (p<0.01). Furthermore, a 
significant increase of the score from PRE to POST evaluation epoch was found 
in the PBC group (p<0.001).  
The same results were found on PGWBI domains; namely, no differences were 
found between groups at PRE, whilst significant improvements were found in 
POST evaluation epoch in PBC group with respect to CONTROL group. In 
particular, significant interactions between TIME and GROUP were found in 
anxiety (F(1,26)=24.08, p<0.001), well-being (F(1,26)=27.52, p<0.001), self-
control (F(1,26)=17.35, p<0.001), general health (F(1,26)=27.67, p<0.001), and 
vitality (F(1,26)=50.19, p<0.001). In all these domains post hoc analyses 
revealed that PBC group at POST significantly improved with respect to 
CONTROL group (always p<0.05). From PRE to POST evaluation epochs a 
significant increase of the scores in all these domains were found in the PBC 
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group (always p<0.001). Concerning the depression domain, Mann-Whitney 
comparisons showed no differences between groups at PRE and a significantly 
higher value in PBC group than in CONTROL group in POST (p<0.001). 
Wilcoxon tests revealed a significant increase from PRE to POST in PBC group 
(p<0.01) and no difference in the CONTROL group.  
 
 
 
Figure 9 Global scores of the Psychological General Well-Being Index (PGWBI) obtained in the 
two groups (PBC: partial-body cryotherapy; Control: Control group) before (PRE) and after 
(POST) the intervention period. **p<0.01; ***p<0.001. 
 
Regarding VASFIQ global score (fig. 10), Mann-Whitney comparisons showed 
no differences between groups at PRE and a significantly lower value in PBC 
group than in CONTROL group in POST (p<0.001). Furthermore, Wilcoxon tests 
revealed a significant increase from PRE to POST in PBC group (p<0.01).The 
same pattern of results was found also for the VASFIQ domains work, pain, 
fatigue, sleep, stiffness, anxiety, depression; namely, no differences appeared 
between groups at PRE, whilst significant improvements (lower values) were 
obtained in PBC group with respect to CONTROL group at POST as shown by 
the results of the Mann-Whitney comparisons (always p<0.01). Wilcoxon tests 
for all the domains showed significant lower values in PBC group (always 
p<0.01) and no differences in CONTROL group.  
In particular, the mean value of VASFIQ global score did not differ at the 
baseline between PBC group and Control group (p=0.29). After 10 PBC 
sessions PBC group showed a highly significant (p<0.00001) decrease in the 
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VASFIQ global score. Similarly, the mean value of the PGWBI global score did 
not differ at the baseline between the PBC group and the Control group (p=0.39). 
After 10 PBC sessions there was a remarkable improvement in the PBC group 
in all items (Depression p<0.01, Anxiety, Well-Being, Self-Discipline, General 
Health and Vitality p<0.001) with no significant changes in any of these items for 
the Control group (p>0.05).  
 
 
 
Figure 10: Global scores of the VASFIQ scale (composed of Fibromyalgia Impact Questionnaire 
-FIQ- and Visual Analog Scales -VAS-) obtained in the two groups (PBC: partial-body 
cryotherapy; Control: Control group) before (PRE) and after (POST) the intervention period. 
**p<0.01; ***p<0.001. 
 
6.7  DISCUSSION 
 
Data obtained in previous studies using health-related self-questionnaire 
indicated that after cycles lasted from 10 to 15 WBC sessions there was a 
significant improvement in the group of fibromyalgic patients, compared to 
baseline condition and to control groups. Particularly, Bettoni and colleagues 
(2013) and to Vitenet and co-workers (2018) demonstrated that the mean values 
of the responses to the quality of life questionnaire for each variable increased 
significantly after completed the WBC cycle compared with the baseline 
(p<0.01). In our study, cryotherapy was performed in a cryocabin, and we 
showed that partial-body cryotherapy induced significant improvements in all 
variables both of the PGWBI and of the VASFIQ scale compared with pre-
treatment condition and with control group. Our findings are in line with those of 
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Rivera and colleagues (2018) who evaluated the efficacy of multiple partial-body 
cryotherapy exposure on patients with fibromyalgia measuring pain by a visual 
analogue scale (VAS), burden of disease by the Fibromyalgia Impact 
Questionnaire (FIQ) and severity of Fibromyalgia with the Combined Index of 
Severity of Fibromyalgia (ICAF) with a significant improvement in all scores after 
the cryostimulation period. To our best knowledge their research is the only one 
carried out in a cryosauna cabin involving patients with a diagnosis of 
fibromyalgia. 
The improvements on self-reported quality of life indixes might originate from 
the balance between pro-inflammatory and anti-inflammatory mediators, which 
have been found to influence pain modulation and, consequently, quality of life 
(Vitenent et al., 2018) and from the above mentioned analgesic effect of the 
cooling agents. According to our explanation of pain reduction sensitivity after 
very-low temperatures exposures Bettoni and colleagues (2013) attributed the 
positive effects of cryostimulation on the referred pain sensation to the changes 
in nerve conduction induced by cryogenic temperatures. In their manuscript 
Rivera and colleagues (2018) indicated as a key point for explain the 
mechanisms of action of cryotherapy in fibromyalgia patients the relieve of 
stress by the activation of neuroendocrine and metabolic functions, specially in 
fibromyalgia patients which constantly deal with stress. Further studies are 
needed to demonstrate the effects of the cryostimulation exposures over time, 
because only in the research conducted by Vitenent and colleagues there was 
a follow-up period (one month). 
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7. METHODOLOGICAL CONSIDERATIONS 
 
In all studies the same cold exposure protocol was utilized, in order to 
standardize the results and to bridge the gap in the standardization of 
procedures in the field of cryostimulation research. 
 
In study I we recruited participants of both genders, while in study II and III we 
involved only female participants. In literature (Cuttel et al., 2017) has been 
observed sex differences in mean skin and mean body temperature following 
very-low temperature exposures, that is why gender differences should be taken 
into account in order to optimize treatment. Further researches are required to 
investigate more deeply the influence of sex and body composition on the effects 
of cryotherapy, in order to take into account these differences in an attempt to 
optimize treatment, when cryotherapy is prescribed.  
 
An interesting way to assess the efficiency of cryotherapy and to compare the 
effects described in different studies is to evaluate the variations in skin 
temperature induced by exposure to very low temperature. In study II skin 
thermal responses were measured, in order to assess the cooling of the low-
back area where the pain-pressure test was applied. Indeed, the absence of this 
measure in experimental procedures based on cryotherapy technologies 
represents a possible limitation, because reporting as many data as possible 
about the cooling of skin and muscles after a determined protocol of PBC it could 
be the better way to contribute to the standardization of cryotherapy/ 
cryostimulation exposure. 
 
In all studies we did not carried out a follow-up investigation. As a consequence, 
we can only talk about acute effects of a single or multiple exposures to very-
low temperatures. Promote the knowledge about the lasting of the benefits of 
cryostimulation procedures should be one of the objectives of our further 
studies.  
 
 
 
 80 
8. PERSPECTIVES 
 
Even if the molecular mechanisms activated, or inhibited, by whole- and partial-
body cryostimulation are still unknow, these cold-treatments are experiencing 
considerable development in several domains such as medicine, health and 
sports. However, as shown in previous chapters of this work, there is a lack of 
information concerning the optimal protocols in terms of temperature inside the 
devices, time of exposure and number of sessions. Even if in the last decade 
there has been an increasing number of scientific articles on this topic, it is still 
necessary establish a method to ensure first of all the safety and consequently 
the therapeutic efficacy for the final users.  
This work contributes to the optimisation of partial-body cryotherapy treatments, 
especially in the field of isometric strength recovery, low-back pain management 
and quality of life assessment in patients suffering of fibromyalgia.  
For our experiments we choose protocols of exposure reported in previous 
published articles. It would be interesting to study the effects of different 
protocols in different populations, considering also the anthropometric 
characteristics and gender of the people recruited. 
From a clinical point of view, comparing our findings with those published by 
other authors, whole- and partial-body cryotherapy are clearly effective in 
improving the pain sensation, the clinical condition and the quality of life both in 
healthy people and specially in several inflammatory and autoimmune diseases.  
That is why we agree that the introduction of very-low temperatures exposures 
into the standard physiotherapy protocols for patients with inflammatory 
diseases in fully justified.  
In the last decade the number of facilities offering cryostimulation devices has 
been grown exponentially, so it make sense to think that once the exposure 
protocols will be validated, an increasing number of people will have a marked 
improvement in the quality of life thanks to this kind of treatments.  
Also in the field of sport recovery there is a growing interesting about these kind 
of techniques. At the beginning rugby players was the first to enter in 
cryochambers to optimize recovery (Banfi et al., 2010): nowadays 
cryochambers and cryocabins can be found in a multitude of locations closed to 
training centers and sport facilities around the world. Elite athletes are 
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increasingly undergoing to cryostimulation sessions, so consequently a large 
number of sportsmen who usually take their favorite champions as examples, 
have started trying cryostimulation. The periodization of the training load and of 
the recovery sessions is crucial for every kind of athlete, so, to ascertain the 
appropriation of its use, future investigations should seek to assess the use of 
cryostimulation at various phases of competitive sports season. 
The role of the scientific community it will be to develop research to demonstrate 
the benefits of whole- and partial-body cryotherapy in many fields of interest and 
try also to establish a certification not only for the devices, but also for the 
operators, which they must master the fundamentals concerning human 
thermogenesis, physiology and safety rules of cryostimulation.  
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9. CONCLUSIONS 
 
The main findings and conclusions of this thesis are as follows: 
 
a. A single session of partial-body cryotherapy leads to increase muscle 
isometric strength in healthy people. This finding provides new 
information on the important effects that both whole-body and partial-
body cryotherapy can induce in the context of physical exercise as well 
as in exercise recovery. This is of practical value for coaches and 
practitioners, aiming to include this treatment in order to improve 
physiological performances, such as isometric strength. Particularly, PBC 
could be performed before a training session or a competition, such as, 
for example, climbing and gymnastics ring performances, where 
isometric strength is required. 
 
b. A protocol of repeated exposures to partial-body cryotherapy in healthy 
women  was shown to be efficient in decreasing the skin temperature in 
the low-back region, and to induce a significant increase in pain-pressure 
threshold. It is to be stressed the importance, for future studies, of 
describing the exposure protocols, to evaluate the relationship between 
temperature, duration, number of repetitions and the treatments’ desired 
effects. These studies will allow to optimize the use of 
cryotherapy/cryostimulation under different physiological and 
pathophysiological conditions. 
 
c. The same protocol of repeated exposures to PBC induced significant 
improvements for all indexes and sub-indexes of the quality of life 
questionnaires assessed in fibromyalgic patients, compared with the 
control group. Our results demonstrate the positive effects of PBC on the 
perceived health and quality of life of fibromyalgic patients and they are 
consistent with those obtained with whole-body cryotherapy. In view of 
the systematic multimodal approach to the treatment of fibromyalgia, 
widely accepted in the last few years, our findings suggest that partial 
body cryotherapy can be effectively recommended as a supportive 
 83 
approach in the improvement of health-related quality of life in 
fibromyalgic patients. 
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